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To repair, replace, or regenerate damaged or diseased tissue has been a long-standing, 
albeit elusive, goal in medical research. Here, we characterize patient-derivable mesenchymal 
stem cell types, termed adipose-derived stem cells (ASCs). These cells, which can be derived 
from liposuction fat and lipoaspirate saline, are sources for patient-derivable extracellular matrix 
(ECM), fibrinogen (Fg) and adipose tissue extracellular matrix, and may prove useful for 
synthesizing new bone tissue analogues in vitro.  
Traditionally and rapidly isolated ASCs were thoroughly characterized as multipotent, 
having osteogenic, adipogenic, and chondrogenic differentiation potential, and they exhibited 
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comparable proliferative lifespans. These ASCs also shared an indistinguishable 
immunophenotype when compared to bone marrow-derived mesenchymal stem cells, suggesting 
that these cells are an excellent source for bone following tissue engineering experimentation. 
In order to synthesize bone ex-vivo, electrospun scaffolds of fibrinogen (Fg), 
polydioxanone (PDO), and Fg:PDO blends were seeded with early passage ASCs, fibroblasts, or 
osteosarcoma cells and were maintained for 21 days in osteogenic or regular growth media. 
Constructs were analyzed both histologically and molecularly for evidence of osteoblastogenesis. 
Using SEM, the appearance of regular, mineralized-appearing structures were found in 
osteogenic-induced ASC seeded scaffolds beyond 14 days, only in the scaffolds containing Fg. 
Further, at 21 days of culture, Fg scaffolds with ASCs in osteogenic media became hard and 
brittle. Robust new collagen synthesis and matrix remodeling were observed on all Fg scaffolds, 
the levels of which were elevated over time. Pronounced mineralization was found throughout 
bone-induced ASC scaffolds, while control scaffolds (BJ foreskin fibroblasts) showed no mineral 
deposition (although they did demonstrate excellent cellularity). Analysis of gene expression 
(qRT-PCR) indicated that electrospun Fg supported osteoblastogenesis through the upregulation 
of alkaline phosphatase and osteocalcin gene expression. To confirm our gene expression results, 
osteogenic-induced ASCs on Fg scaffolds were also shown to secrete osteocalcin in the 
extracellular matrix, a key marker in osteoblastogenesis. Thus, electrospun Fg is an excellent 
material for ASC growth, proliferation, and osteogenic differentiation, providing an ideal system 
for furthering basic bone model-based research and for advancing regenerative medicine. 
In addition to establishing Fg as a source of scaffolding, we developed and characterized 
a novel method for isolating and subsequently electrospinning adipose tissue matrix. Because 
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adipose ECM contains many primordial matrix proteins important for embryonic development 
and regeneration (such as laminin, type IV collagen, and fibronectin), adipose ECM may prove 
to be an autologous tissue engineering matrix and stem cell culture substrate. We show here that 
adipose tissue ECM can, in fact, be electrospun into a nanofiberous mesh, histologically shown 
to contain connective tissue, collagens, elastic fibers/elastin, proteoglycans, and glycoproteins in 
the newly synthesized matrix. We also show that this novel electrospun adipose tissue scaffold is 
capable of supporting stem cell growth. Taken together, experiments using ASCs cultured on 
extracellular matrices of electrospun Fg or adipose ECM present an excellent framework for 
future advances in regenerative medicine therapeutics and research. 
 
  1 
-Chapter 1- 
Background and Significance 
Bone: Basic Biology 
Bone, a seemingly simple tissue, carries out a lengthy list of functions in the body 
including, but not limited to, organ protection (skull and ribs), red and white blood cell 
production, mineral storage (phosphorous), and fat storage. Bone holds 99% of the total body 
calcium, a mineral critical for innumerable physiological processes. Bone is also crucial for 
locomotion, heavy metal detoxification, buffering the blood against excessive pH, and providing 
shape to the body, as well as being essential for sound transduction (hearing) (Lieberman and 
Friedlaender, 2005). 
Bone is a special form of connective tissue, composed of microscopic crystals of 
phosphates and calcium within a matrix of collagen, primarily Type I, which is also the major 
structural protein in skin and tendons. This collagen is typically 300nm in length with regular 
67nm banded fibrils in its fundamental unit and is as strong as steel, kilogram-for-kilogram 
(Haralson et al., 1995). Type I collagen is made up of a triple helix of three polypeptides tightly 
bound together, two of which are identical α1 polypeptides, encoded by a single gene, with a 
separate gene producing the third chain, the α2 polypeptide (Haralson et al., 1995).  
Sufficient quantities of protein and minerals are essential for normal bone maintenance. 
Bone crystals, made mostly of inorganic mineral hydroxyapatite (Ca10(PO4)6(OH)2), measuring 
20nm x 3-7nm, comprise 70% of the dry weight of bone (Lieberman and Friedlaender, 2005). 
Sodium and trace amounts of carbonate, magnesium, and other metals are also present in mature 
bone. Macroscopically, most bones are made of a compact outer layer, surrounding trabecular 
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bone and, in many cases, a bone marrow cavity. Trabecular, or spongy, bone is composed of 
bone spicules separated by open spaces or pores that undergo constant remodeling, the dynamic 
physiology of which is critical for maintaining healthy bone. 
In the highly intertwined and dynamic process of bone remodeling, giant multinucleated 
cells, called osteoclasts, function to break down bone matrix. Osteoclasts become multinucleated 
by cell fusion and are believed to be derived from hematopoietic stem cells of the resident bone 
marrow. In an acidification process using hydrogen pumps (with Na+/K+ ATPase; HCO3-/CL- 
exchanger; Na+/H+ exchangers), osteoclasts solubilize and erode bone crystals, followed by the 
release of enzymes to digest remaining bone proteins and the formation of resorption lacunae 
into which osteoclasts burrow (Liebschner et al. 2003). The growing resorption lacunae are 
followed by and partially filled with forming capillaries to supply nutrients to the bone cells. 
Once the lacuna acquires a certain depth, osteoblasts enter the formed cavity and fill it with 
osteoid. The more osteoclasts that are activated, the more bone is resorbed and the more calcium 
released. Trabecular bone becomes increasingly brittle as the number and depth of the resorption 
lacunae increases and the diameter of the remaining trabeculae decreases; whereas, conversely, 
healthy bone of athletes is typified by thick, dense trabeculate.  
New bone is produced by osteoblasts, which are mononuclear cells arising from 
progenitors located in the marrow and the periosteum. Osteoblasts secrete large quantities of type 
I collagen, alkaline phosphatase, and other bone matrix proteins and typically fill resorption 
lacunae as they are created by protagonist osteoclasts. The new bone material, or osteoid, formed 
by osteoblasts is rendered hard through calcium phosphate crystal deposition. Once the 
osteoblast is incorporated into the bone matrix, it becomes quiescent and is known as an 
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osteocyte, occupying a small cavity or bone lacuna in the matrix. From the lacuna, osteocytes 
radiate “arms” through slender channels to communicate with neighboring lacunae. One of the 
more interesting histological features of mature bone is the relative scarcity of cells in the dense 
tissue matrix and the regular spiral patterning created by the bone remodeling process. 
Only 5-20% of the bone typically undergoes remodeling at any time with the rest existing 
in a quiescent state. The local bone remodeling process begins with the activation of osteoclasts 
and concludes with new bone formation by osteoblasts, requiring 3-4 months to complete. In 
healthy individuals, 5-10% of the total bone substance is replaced annually (Liebschner et al., 
2003). 
 
Bone: Regeneration  
Along with the liver and kidneys (nephrons), bone is one of the few tissues in adult 
mammals that can undergo true regeneration, complete with blastema formation and asymmetric 
cell divisions, rather than scarring for wound repair. Healing of a fractured bone in the body 
occurs through distinct yet overlapping stages (Lieberman and Friedlaender, 2005). The first is 
the early inflammatory stage where a fibrin-laced hematoma develops within the fracture. This 
hematoma is a blood clot that originates from lacerated blood vessels in the bone and the 
periosteum. Hematoma formation leads to the infiltration of inflammatory cells such as 
macrophages, monocytes, and lymphocytes, as well as osteoblasts to clean and resorb the 
necrotic bone and inflamed hematoma. Granulation tissue develops from cells of the periosteum 
and endosteum as the hematoma is resorbed, followed by an infiltration of pluripotent 
mesenchymal stem cells into the granulation tissue to begin repairs (Schindler et al., 2008). This 
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granulation tissue formation process is typical of an early stage wound in most mammalian tissue 
types, with the stimulation of an ingrowth of vascular tissues and recruitment of progenitor cells 
as key features. 
In the second stage of healing, the repair stage, the progenitor cells differentiate into 
chondrocytes and later osteocytes, producing cartilage and bone, respectively. These 
differentiated osteocytes can be recognized by the upregulation of common bone-specific marker 
genes and proteins, such as osteocalcin, osteopontin, and bone sialoprotein protein (Liebschner et 
al., 2003). Recruited fibroblasts further lay down a mesh of stroma supporting vascular ingrowth 
in the granulation tissue, with the collagen matrix supporting the osteoid. A soft callus structure 
finally forms around the repair site that fills with woven bone made by the osteoblasts.  
Fracture healing concludes in the late remodeling stage, where healing bone regains its 
original structure, shape and mechanical integrity. This remodeling occurs over months to years, 
shrinking the callus as the trabeculae form along stress lines, and thus, the late healing process is 
highly facilitated by mechanical stress placed throughout the bone to guide its reformation. 
 
Bone: Diseases, Disorders and Clinical Repair Strategies 
Failures of the bone organ can occur as the result of any number of clinical conditions, 
including cancers (osteosarcomas and as a target tissue of metastatic cancers), infections 
(commonly osteomyelitis), blunt traumas that may result in non-unions, and congenital defects 
(e.g. osteogenesis imperfecta). Many of these diseases will result in moderate to extreme pain 
and also partial or total loss of mobility. Furthermore, some bone disorders, while rare in the 
population, are even fatal, as in Osteogenesis Imperfecta Type II, or Brittle Bone Disease, a 
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disease linked to an absence of collagen in quantity and quality, which is seen in  approximately 
6 in 100,000 newborns (Lieberman et al., 2005). 
Though fracture healing usually progresses smoothly, non-unions in bone are prevalent 
when regeneration fails. Non-healing unions are a problem in long bones that is more commonly 
seen with increasing age, and they often result in intense inflammation and pain in the elderly, 
with amputation as a possible consequence. Non-unions from combat related injuries in war have 
also become a major concern. To accelerate bone healing or the closure of non-unions, health 
care providers in many labs and clinics have implemented injecting a basic fibrinogen gel for 
guiding osteogenesis into the fracture, both with and without mesenchymal stem cells added to 
the mixture (Valbonesi, 2006). Fibrinogen-based gels and stem cells have proven to be extremely 
well tolerated and effective in animal models. In humans, most therapeutic strategies have relied 
primarily on progenitor cells derived from the bone marrow, which has patient morbidity 
associated with drilling a large hole in the iliac crest to harvest these cells. The use of 
mechanically unsound gels is also far from ideal especially with microscopic structures in the 
hundreds of microns scale, the latter of which are far from the native few hundred nanometer 
fiber diameters seen in naturally formed hematomas. This finding suggests that a rigid 
replacement tissue would be more clinically desirable (Tamer et al., 2008).  
Among common bone disorders, postmenopausal osteoporosis is estimated to affect 1 in 
3 women, while 1 in 12 men over 50 are believed to have osteoporosis worldwide. The 
mechanism behind osteoporosis is linked to an imbalance between bone resorption and bone 
formation (Figure 1), where bone mineral density decreases, the spicules of trabeculae become 
thin and break, and the amount and variety of non-collagenous proteins differ from a normal  
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Figure 1. Healthy and Osteoporotic Trabecular Bone.  A low power scanning electron 
micrograph (SEM) image of normal 3rd lumbar vertebra bone architecture from a 30 yr old 
woman (upper left, with marrow and cells removed), showing thick interconnected plates of 
bone, is compared to osteoporotic bone in the same region from a 71 yr old woman  (with 
marrow and other cells removed), revealing eroded bone (by kind permission of Tim Arnett and 
the Bone Research Society). 
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healthy state. Osteoporosis is responsible for millions of fractures annually, mostly involving the 
hip, wrist, and lumbar vertebrae, with rib fractures also common in men. Annually, at least 
250,000 hip fractures are attributed to osteoporosis in the U.S alone (Lieberman and 
Friedlaender, 2005). As the incidence of osteoporosis increases in the elderly, the incidence of 
bone fracture increases as well, often with little to no subsequent repair occurring; which can 
greatly affect life expectancy and the quality of life. 
Along with a need for rejuvenating bone in the elderly, bone tissue and bone substitutes 
are needed for the treatment of several pathologies ranging from calvarial defects to non-healing 
fractures. In the U.S. alone, over 500,000 surgical procedures are performed annually, that 
require new bone tissue or bone analogues (Langer et al., 2003). While cadaveric bone grafts 
have proven highly effective clinically, donated bone tissue can have underlying infections or 
cause immunological rejection. Further, donor bodies for bone are rare, which has created a 
black market for stolen cadaveric bone tissue with thousands of stolen cadaver bones thefts being 
recently uncovered by one company alone (Powell et al., 2006). 
 
Stem Cells  
Stem cells are defined functionally as a cell type having the ability to self-renew with the 
capacity to form differentiated cells (Weissman et al., 2001). Most somatic stem cells are mortal, 
while embryonic stem cells are capable of extensive proliferation. Importantly, stem cells are 
said to be clonogenic, with single cells capable of creating more stem cells, both in the body and 
in culture. Stem cells exhibit variable potency including: (1) a totipotent or pluripotent 
embryonic stem cell that can differentiate into all cell types in the adult organism; (2) 
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multipotent mesenchymal stem cells that can form a handful of lineages; and (3) unipotent 
progenitor cells that only produce a single type of differentiated descendent.  
The clonal nature of marrow cells was revealed over 45 years ago (Becker et al., 1963; 
Siminovitch et al., 1963). Friedenstein and colleagues later developed an assay for examining the 
clonogenic potential of these multipotent bone marrow-derived mesenchymal stem cells (BM-
MSC) (Friedenstein et al., 1974 & 1976). MSCs are believed to be multipotent cells that are able 
to replicate as undifferentiated cells and are also well known for their potential to give rise to 
myocytes, adipocytes, chondrocytes, and osteoblasts. Thus, these cells appear to be capable of 
differentiating through complex, interrelated genetic pathways that only recently are becoming 
understood (Sensenstien et al., 2008). In osteoblast differentiation, for example, Runx2 
expression is essential to initiate osteogenesis, along with osterix and other genes acting 
downstream of Runx2 to induce mature osteoblasts that express mature osteoblast markers, such 
as osteocalcin (Sensenstien et al. 2008). 
 
Adipose-Derived Stem Cells 
Where BM-MSCs have been the most widely studied of the MSC types, the existence of 
an analogous adipose stem cell source in human fat is becoming aparent (Zuk et al., 2001; Zuk et 
al., 2002). ASCs have gained considerable interest, in part, due to sharing a nearly identical 
transcriptome, immunophenotype (Katz et al., 2005), and differentiation potential (Izadpanah et 
al., 2006; Kern et al., 2006; Zuk et al; 2001 & 2002; Gimble et al., 2007) with their sister MSC 
cells from bone marrow. 
In many ways, ASCs appear to be an advantageous cell type relative to BM-MSCs, since 
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they are 1,400 times more abundant (Izadpanah et al., 2006, Kern et al., 2006) and a more readily 
accessible tissue source relative to bone marrow. Liposuction also offers greatly reduced patient 
morbidity relative to tapping into the bone marrow. Although controversial, some evidence 
suggests that ASCs may be an immune-privileged (Rodriguez et al., 2005), or at least an 
immunomodulatory cell type that repels host immune cells (Hoogdujin et al., 2007). 
Additionally, ASCs are able to restore lethally irradiated bone marrow and fully re-populate the 
hematopoetic system (Chamberlain et al., 2007), suggesting the potential for allogeneic ASC 
transplantation. Furthermore, ASCs are reported to secrete potent growth factors in high 
quantities, such as basic fibroblast growth factor (bFGF), insulin-like growth factor 1 (IGF-1), 
hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF) (Wang et al., 
2006). These factors are crucial for tissue development and regeneration and will likely prove to 
be essential for constructing many artificial tissues.  
 
Mesenchymal Stem Cells in the Clinic 
Therapeutic use of mesenchymal stem cells for skeletal tissue regeneration, repairing 
bone fractures and treating congenital bone-related diseases is flourishing and appears to be an 
area of research with encouraging results (Arthur et al. 2009). Their multipotency, immune-
modulatory properties, and secreted paracrine factors make ASCs ideally suited for regenerative 
medicine purposes, and their clinical use, along with BM-MSCs, has been well investigated over 
the past 2 decades.  
In a healthy individual, MSCs within skeletal tissues contribute to the repair and normal 
remodeling process by providing a pool of osteoblasts to create the mineralized matrix of bone 
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(Bielby et al., 2007), yet anomalies such as non-union fractures, osteoarthritis, osteosarcomas, 
osteoporosis, and infections can interfere with the natural regenerative process. While it may 
seem obvious that ectopic transplant of MSCs to a bone defect site may aid in healing, 
regenerating 3D tissue, such as bone, is complex with a number of elements that are critical for 
coordinating the formation of a functional tertiary structure (Menicanin et al., 2007). While 
administering stem cells alone provides some degree of benefit in neuronal, hematopoietic, and 
cardiac regeneration, stimulating skeletal regeneration is proving to be most effective when using 
stem cells along with the mechanical and structural support provided by a scaffold (Arinzeh, 
2005; Mastrogiacomo et al., 2006; Kanxsler and Oreffo, 2008). 
In large animal studies, transplanting MSCs alone or in porous ceramic scaffolds made of 
hydroxyapatite significantly stimulated new bone growth in a non-union fracture model, with 
treated animal bones becoming as strong as uninjured control bones 8 to 32 weeks after 
treatment (Kon et al., 2000; Liu et al., 2008). In analogous human trials, 16-, 22- and 41-year old 
patients with non-union fractures having 4-7cm critical size defects were treated with autologous 
MSCs seeded in defect-sized hydroxyapatite scaffolds (Quarto et al., 2001). All 3 patients 
regained function of the injured limb without side-effects and with callus formation within 2 
months. Patients reached a recovery stage within a few months that traditionally would take 1-
1.5 years to attain using traditional bone grafting methods (Quarto et al., 2001). 
In treating craniofacial defects, Lendeckel and colleagues (2004) reported a case study 
where a 7-yr old girl who had suffered widespread calvarial defects with complicating chronic 
infection was treated with autologous ASCs, using an autologous fibrin glue to retain the stem 
cells in the defects. Three months after reconstruction, extensive new bone formation and nearly 
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complete calvarial continuity was observed, with total repair occurring by 24 months. ASCs 
were used in this treatment partially because autologous bone from the iliac crest was limited, 
making sufficient BM-MSCs unavailable for treatment. 
The first MSC trials addressing osteogenesis imperfecta (OI) in children (Horwitz et al., 
1999, 2001, 2002) demonstrated that un-manipulated, HLA-matched sibling bone marrow and 
MSCs were safe and effective when administered by intravenous infusion. In these studies, the 
transplants were well tolerated, lacking any apparent immunological response. Osteoblast 
engraftment from donor tissue was observed in all patients, and bone mineral volume and overall 
growth was noted, along with a reduction in fracture frequency relative to age-matched controls. 
Subsequent studies demonstrated the feasibility of culture expansion and modification of cells 
prior to treatment of OI as well (Horwitz et al, 2002). 
Collectively, these advantages make ASCs an excellent stem cell source, an ideal bone 
progenitor cell, and a cell type with significant therapeutic potential. However, stem cells do not 
exist or repair tissue in a vacuum; rather, they are dependent on an intricate, three-dimensional 
extracellular matrix network. 
 
 
Extracellular Matrix: 
Basic ECM Biology, Functions and Types 
Traditionally thought of as merely the structural component for cell and tissue support, 
extracellular matrix (ECM) has been established as being of utmost importance throughout 
biology the past 30 years. Four major classes of macromolecules—collagens, structural 
glycoproteins, proteoglycans, and elastin—collectively comprise the ECM of animal cells, being 
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both widely distributed and multifunctional throughout the body (Table 1). ECM is constantly 
synthesized, secreted, oriented, and modified by the cellular components that they support. All 
ECM molecules, apart from elastin, contain families of related proteins derived from uniquely 
arranged gene products. Members of each family and class of ECM molecules exhibit a degree 
of tissue-specific distribution, implicating the ECM in development and tissue function. 
Additionally, specific cell surface receptors have been identified on ECM components, linking 
the biology of the cell with its ECM interactions.  
Some of the more critical known functions of native ECM include: 
(1) Contributing mechanical and Structural Support 
(2) Providing Cell Anchoring Sites 
(3) Aiding Cell-Cell and Cell-Matrix Communications 
(4) Directing Cell Orientation 
(5) Controlling Cell Activity 
(6) Maintaining or Inducing Differentiation 
(7) Establishing Microenvironment (Sequesters & Presents Regulatory Molecules) 
(8) Guiding Embryonic, Fetal, and Somatic Tissue Development 
(9) Providing Provisional Wound Healing Substratum  
(10) Forming Tissue Barriers 
(11)  Selectively Inhibiting or Promoting Cell Migration or Proliferation 
 
The ECM is believed to influence cells through at least two families of cell surface 
receptors: integrins and syndecans. Cells have been shown to produce extracellular matrix based 
on a delicate interaction between regulatory signals from growth factors and cytokines, vitamins 
and hormones, and cell-to-cell contact (Lutolf and Hubbell, 2005). Furthermore, many of the 
biological effects attributed to cytokine and growth factor effects on a cell are nearly identical to 
the effects imparted by ECM itself on cells, such as a modification in the state of differentiation, 
metabolic responses, and growth.  
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Table 1: Major ECM Components, Their Functions and Localizations.#  
Component  Functions  Localization 
Collagens  
(Types I - XVIII) 
Tissue architecture, tensile 
strength, cell-matrix interaction, 
matrix-matrix interaction 
Widely distributed (skin, 
tendon, ligament, cornea, 
lung, bone, basement 
membrane, etc.) 
Elastin  Tissue architecture, elasticity  Tissues requiring elasticity  (lung, blood vessel, skin)  
Proteoglycans  
Cell-matrix interaction, matrix-
matrix interaction, cell 
proliferation, cell migration 
Widely distributed (cell 
surface, neural tissues, 
liver, basement membrane) 
Glycosamino-
glycans  
Cell-matrix interaction, matrix-
matrix interaction, cell 
proliferation, cell migration  
Widely distributed 
(synovial fluid, connective 
tissue, etc.) 
Laminin  
Type IV collagen interactions, 
cell binding, cell development, 
migration, differentiation, wound 
healing, morphogenesis, 
angiogenesis 
Basement membranes and 
widely in developing 
embryo and fetus 
Fibronectin  
Cell differentiation, proliferation 
and migration, tissue architecture, 
cell-matrix interaction, matrix-
matrix interaction 
Widely distributed 
(Plasma, produced by 
fibroblasts, epithelial and 
endothelia cells, platelets, 
etc.) 
Fibrinogen  Blood clotting, cell proliferation, cell migration, hemostasis Blood and wound healing  
#Adapted from Palson et al., 2004 
   
 14 
The function and fate of a cell is largely orchestrated by extrinsic and intrinsic factors, 
suggesting that the new cellular paradigm holds that beyond genetic programming, four major 
types of interactions—growth factors/cytokines, hormones/vitamins, cell-to-cell contact, and the 
ECM—regulate the growth, shape, differentiation state, biochemical responses, and development 
of the cell. Each of these interactions are translated through specific cytoplasmic or cell surface 
receptors and affect changes in gene expression, which in turn alter ECM expression itself in a 
phenomenon called “mutual reciprocity” (Palson et al., 2004). Complicating this whole process 
is the observation that ECM, with its extensive binding sites present on its surface, is specifically 
associated with many cytokines and growth factors (Rapraeger, 1993; Vlodavsky et al., 1993). 
Thus, it is becoming clear that the extracellular matrix plays a pivotal role in a cell’s biological 
phenotype, especially related to its normal development/function and its pathological responses. 
 
ECM in Development 
Throughout embryonic and fetal development, extracellular matrix interactions 
orchestrate such activities as cell migration and proliferation, stem cell differentiation, tissue 
patterning, and morphogenesis (Campbell et al., 2005, Flaim et al., 2005, Haylock et al., 2005, 
Kihara et al., 1998, Naugle et al., 2006, Suzuki et al., 2003). The ECM interacts directly with cell 
surface receptors, acting as a reservoir for growth factors and morphogenetic proteins, or simply 
providing a scaffold for cell attachment and cell migration. Even cell morphology is determined 
by contact with the ECM, which may be associated with cell differentiation and proliferation. 
For example, floating type I collagen gel can induce functional differentiation of precursor cells 
into mammary glands, mediated through changes in cell shape, thereby allowing branching 
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morphogenesis to occur (Bissel et al., 1987). Further, laminin-I is expressed in developing mouse 
lung by epithelial and mesenchymal cells where it is essential for branching morphogenesis 
(Schuger et al., 1991). The biomechanics of the scaffold also plays a crucial role in development. 
For example, the rigidity of the ECM substrate alone can induce the differentiation of precursor 
cells into hepatocyes and direct their morphogenetic pattering in the developing liver (DiPersio 
et al., 1991). 
Basement membranes are common to tissues of nearly all multicellular metazoans, and 
their gene products are highly conserved and among the most ancient (Exposito et al., 2002; 
Hutter et al., 2000). Basement membrane (or basal laminae) proteins are the first ECM materials 
to appear during embryogenesis, with laminin being the first detectable ECM protein that 
appears shortly after morula differentiation. In what can be called the first true tissue to form in 
development, the morula consists of the inner cell mass, trophectoderm, and primitive endoderm 
(Martin and Timpl, 1987, Miner et al., 2004).  
Assembled basal laminae are the earliest ECM recognized as a distinct structural entity. 
Throughout development of the embryo and fetus, basement membrane and other ECM materials 
assemble in nearly all tissues, having a profound effect on their developmental fate. Loss of 
phenotype studies in C. elegans (Kramer, 2005) have shown that several basement membrane 
components, including type IV collagen, laminin, perlecan, and possibly osteonectin/SPARC, are 
necessary for tissue organization and structural integrity, the latter of which is essential for the 
completion of embryogenesis. Type XVIII collagen and nidogen, while not critical for 
embryonic or fetal viability, play primary roles in organizing the nervous system. All of these 
proteins further have a role in gonad development (Kramer, 2005).  
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The Stem Cell Niche 
The stem cell niche concept holds that a highly specialized microenvironment is 
responsible for sustaining a stem cell pool in every tissue and organ system (Scadden, 2006). 
This specialized microenvironment consists of the local ECM, its stored growth factors, and the 
3D ultra-structure of the niche, including the cell-cell contacts and the signals shared with 
parenchymal cells in the environment surrounding the stem cells (Haylock and Nilsson, 2005; 
Moore and Lemischka, 2006).  
The ECM in particular has proven to play a critical role in niche formation, being first 
recognized to support the hematopoietic stem cell (HSC) niche through binding heparan sulfate 
proteoglycans (Daley et al., 2007; Gupta et al. 1998). Additionally integrin-ß1 has proven to be a 
potent stem cell marker that aids in restricting stem cells to the epidermal stem cell niche through 
MAP kinase signaling (Jensen et al., 1999; Zhu et al., 1999). The integrins, readily bound by 
numerous ECM binding sites, are key in communicating extracellular signals to stem cells, 
regulating cell proliferation, cell survival, and cell migration out of the niche (Leone et al., 
2005), and even for niche-to-niche homing through extensive microenvironment interactions 
(Lapidot et al., 2005). 
For HSCs, the bone surface lining, or endosteum, is identified as their major niche with 
resident osteoblasts maintaining HSCs in a quiescent state (Arai et al., 2004). Additionally, in the 
HSC niche, the phosphorylated glycoprotein osteopontin, secreted by osteoblasts, incorporates in 
the ECM and interacts with a vast array of integrins and CD44 on HSCs surface to inhibit stem 
cell expansion (Nilsson et al., 2005; Stier et al., 2005). In neural stem cell migration, laminin 
alone has been found sufficient in vitro for initiating neural stem cell outgrowth from a 3D 
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neurosphere (Flanagan et al., 2006). Interestingly, the ECM alone is able to induce osteogenesis 
with laminin-332 stimulating MSC osteogenic differentiation through ERK signaling (Klees et 
al., 2005).  
Osteogenesis can also be induced through collagen type I or vitronectin contact, mediated 
through ERK-1/2 stimulation and the early stage osteogenic transcription factor Runx2 
(Salasznyk et al., 2007). Cytoskeletal tension imparted from the ECM is also reported to induce 
osteogenic differentiation of MSCs, perhaps through RhoA/ROCK signaling (McBeath et al., 
2004). Human MSCs are also inducible into many other cell types through contact with the 
ECM. Recent work suggests that endothelial cell matrix induces gene and protein marker 
expression, as well as functional gains of genuine vascular cell phenotype, with the endothelial 
cell matrix found to be an essential substrate for inducing vascular cell differentiation in MSCs 
(Lozito et al., 2009). 
 
REGENERATIVE MEDICINE: 
Basic Theory & Principles 
Regenerative medicine, now synonymous with tissue engineering, is a rapidly expanding 
interdisciplinary field involving biological sciences (embryology and wound healing, cell 
biology, and physiology), medicine (surgery and transplantation, pathology, immunology, and 
radiology), and engineering (materials science, mechanics, fluid dynamics, chemical kinetics, 
and transport phenomena). This field employs a staggering number and range of biotechnologies 
(Langer and Vacanti, 1993). As such, regenerative medicine is revolutionizing the way scientists 
and clinicians improve the health and quality of life for millions of people worldwide through 
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restoring, maintaining, and/or enhancing organ and tissue function while confronting aging as a 
treatable disease. Beyond therapeutic applications, engineering tissues ex vivo has great potential 
for clinical applications, where synthetic tissue can be used to test drug metabolism and uptake, 
toxicity, and pathogenicity (Langer and Vacanti, 1999). 
In practice, regenerative medicine is a field closely associated with any application used 
to replace or repair portions of or all of a tissue, ranging from blood vessels, cartilage, heart, 
bone, bladder, and other tissues. The recent, rapid explosion of stem cell biology advances has 
only further stoked the enthusiasm for the tissue engineering field, while creating potential raw 
material sources previously unavailable. Because many somatic cell types have been extremely 
difficult to isolate and expand in sufficient numbers to regrow or repair damaged tissue, stem cell 
biology is likely to eliminate this as an obstacle. While significant research is in progress under 
the umbrella of tissue engineering, we are particularly interested in the creation of biomimetic 
scaffolds that resemble native ECM relevant to our studies.  
From the inception of the regenerative medicine field, three major strategies have 
dominated therapeutically: 1) a purely cellular approach that injects cells alone into the patient, 
directly or indirectly into the diseased or defective tissue; 2) a cell encapsulation system for cell 
support; and 3) the ex vivo growth and development of cells in a supporting scaffold prior to 
implantation (Nussbaum et al., 2007). Since almost all tissues and organs in the body appear to 
contain parenchymal (functional) and progenitor or stem (support) cells situated within a 
dynamic supporting ECM microenvironment, the third approach has gained considerable favor. 
In producing a supporting scaffold for tissue repair or replacement, the biomimicry of actual 
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bodily tissue matrices is a natural, logical approach, especially given the importance and 
influence of the ECM. 
Since the ECM has been shown to be crucial for orchestrating developmental, 
regenerative, and wound repair/healing cues, it is logical to incorporate related natural ECM 
components in any engineered scaffold design, with biologically relevant nanofibers, cytokines, 
and cell binding sites available for cell growth, migration, and differentiation. While crudely 
injecting stem cells alone has some therapeutic promise in certain situations, application of the 
cells in a controllable manner directly to the target site has clear advantages. This has driven the 
tissue engineering field for developing bioscaffolds for cell delivery such that countless materials 
and material forming methods have been examined to address the many challenges of creating an 
idealized biomimetic, biocompatible, degradable, and semi-rigid matrix for natural cell growth 
and development.  
Common gels, such as the mouse sarcoma-derived Matrigel and denatured collagenous 
gelatin, have proven very useful in vitro but are far less effective clinically due, in part, to the 
associated immune response and lack of mechanical integrity (Song et al., 2006). Other scaffolds 
based on natural materials, such as decellularized tissue (Gilbert et al., 2006), while tedious to 
create and complicated by lack of available starting materials, have shown significant promise, 
both at the bench and bedside. A more elegant and pliable scaffold building process has long 
been needed, and one such emerging process is electrospinning. 
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SCAFFOLD FABRICATION 
Electrospinning 
In its basic form, electrospinning involves the application of a 15 to 30kV DC electric 
potential to a polymer solution or melt, which is held in a syringe separated from a grounded or 
oppositely charged target. This creates an electrostatic field that when sufficiently high in 
strength allows the electric potential to overcome the solution surface tension resulting in the 
ejection of a small jet (via a Taylor Cone) of intertwined polymer chains. This stream whips 
around in space towards the target as driven by the charge repulsions between and within the jet. 
The solutions of charged polymers are typically dissolved in an organic solvent, and with 
optimized polymer concentration and jet travel distance, the solvent evaporates as the polymer 
flies to its target/mandrel and leaves a dry polymer fiber that collects as a non-woven fibrous 
mesh (Barnes et al., 2007) (Figure 2). Electrospun fiber sizes and scaffold porosity parameters 
can be crudely tailored as desired through altering starting polymer concentrations. The fibrous 
mat can be further customized through target translation and rotation speed changes to orient the 
fibers in a controlled manner, from paralleled, aligned fibers to a randomly oriented mesh.   
 The recently evolved electrospinning technique for bio-scaffold construction is rapidly 
gaining favor in the tissue-engineering field due to its numerous advantages over conventional 
scaffold methods. Natural matrix materials, such as collagen, laminin, elastin, and fibrinogen 
with or without supporting synthetic blends, can be spun into scaffolds of nearly any shape and 
microscopic properties. Electrospun scaffolds highly resemble native extracellular matrices in 
geometry, fiber size, and material composition. While conventional polymer processing 
techniques for producing fibers generally create fibers 10 micrometers or larger in diameter, the  
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Figure 2. Electrospinning Apparatus Schematic.  The elements of a basic electrospinning 
setup are shown, with a high voltage power supply connecting to the needle of a syringe filled 
with matrix polymer, for electrospinning fibers of the polymer material through the generated 
electric field, with fibers collecting on a rotating mandrel that is connected to ground. 
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nanofibers generated from electrospinning are capable of mimicking the sub-micron diameter 
and geometry typical of endogenous tissues. 
 
Cross-Linking 
Chemical cross-linking is commonly applied to tailor degradation rates and 
biomechanical characteristics of a tissue engineering scaffold, typically to match the properties 
of the target tissue for regeneration. However, many of these cross-linking chemicals can reduce 
biocompatibility, to the point that even the more popular cross-linking agents, such as 
glutaraldehyde (GLUT), formaldehyde, and epoxy compounds, have proven cytotoxic. This 
toxicity is likely due to the reactive moieties covalently coupled between adjacent collagen 
fibrils (Koob, 2004; Jayakrishann and Jameela, 2006; Badylak, 2002; Khor, 1997).  
Many electrospun natural materials, such as collagens and elastin, shrink and disintegrate 
upon hydration in any aqueous solution. Therefore, cross-linking has been required to maintain 
structural integrity of many scaffolds. However, even natural electrospun scaffolds cross-linked 
in GLUT have a tendency to gel and lose their most important feature, their nanofibrous 
architecture, by fusing the fibers into a thick mat.  
As fibrinogen is actively broken down by thrombin and other serum proteases, it was 
reasoned in prior work that electrospun fibrinogen should be cross-linked for cell-based studies 
in order to maintain scaffold integrity in vitro and in vivo (McManus et al., 2006 & 2007). 
Electrospun fibrinogen exhibits excellent bioactivity, yet was reported to exhibit poor 
mechanical integrity after a few days in culture (McManus et al., 2006, 2007, 2009). Ideally, a 
suitable cross-linker would slow the degradation rate of fibrinogen while not affecting the 
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bioactivity of the scaffold. Although fibrin clots have native factor XIII (transglutaminase) cross-
linking, which forms a covalent bond between the lysyl and glutamyl residues of adjacent fibrin 
molecules (Achyuthan et al., 1988; Dickneite et al., 2002; Mosesson et al., 2005), this compound 
(transglutaminase) is cost prohibitive. Other agents may prove more cost effective while 
supplying similar biologic properties. To bypass chemical cross-linking, our laboratory has 
successfully electrospun blended natural materials with synthetic polymers (Barnes, 2005), 
which is a highly promising practice.  
Among candidates for cross-linking fibrinogen (and possibly for adipose tissue ECM), 
GLUT is the most commonly used cross-linker for collagen tissue fixation (Olde Damink et al., 
1996; Sung et al., 2003). GLUT is cost effective and fast acting, and it cross-links over varying 
distances while reacting with numerous amino groups in target proteins (Jayakrishnan and 
Jameela, 2006). GLUT, however, exhibits increased cytotoxicity and material calcification over 
time (Olde Damink et al., 1996; Sung et al., 2003).  
The hetero-bifunctional carbodiimide 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) has been successfully used to cross-link electrospun elastin (McClure et al., 
2007) and type II collagen (Barnes et al., 2007). EDC has the advantage of not being 
incorporated into the target macromolecule, known as a zero-length cross-linker, which in turn 
reduces the potential for cytotoxicity (Olde Damink et al., 1996; Sung et al., 2003).  
Genipin, which is derived from the fruits of Geninpa Americana and Gardenia 
jasminoides Ellis, is a naturally occurring cross-linker that has been used for collagenous tissues 
(Sung et al., 2003). Genipin is effective in increasing material tensile strength and toughness 
while being far less cytotoxic then GLUT (Tsai et al., 2000), making it an ideal cross-linker for 
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fibrinogen where high mechanical strength is important. Our studies have determined the 
effectiveness of these cross-linkers for electrospun fibrinogen scaffolds. A particular goal of this 
study was to determine which cross-linker increases the mechanical properties, slows 
degradation, and, importantly, maintains the high level of bioactivity inherent in fibrinogen.  
 
SCAFFOLD DESIGN 
MATERIAL SELECTION: Fibrinogen 
Fibrinogen is an integrin-spanning glycoprotein produced in the liver that binds collagen, 
fibrin, and heparan sulfate. Clinically used since at least 1944, fibrinogen is applied widely as a 
fibrin glue sealant or gel, used for treatment of burns and wounds, congenital cardiopathies, 
peptic ulcers, cardiac bypass surgeries, and especially in plastic surgery and many other 
applications (Mosesson, 2005). Fibrin(ogen) contains a ß15-42 sequence for binding heparin, 
allowing for active cell-matrix interactions. Fibrinogen has been shown to mediate endothelial 
cell spreading and fibroblast proliferation, capillary tube formation and proliferation, and is a 
von Willebrand factor releasing agent (Valbonesi, 2006). Conveniently, it uses binding 
site/factors that are also germane to ASCs (Katz et al, 2005).   
Additionally, fibrinogen actively binds fibroblast growth factor-2 (FGF-2, bFGF), a 
crucial stem cell signaling molecule, as well as vascular endothelial growth factor (VEGF). Both 
of these functions may potentiate endothelial cell proliferation and may contribute to the healing 
response. Of note, ASCs have been shown to secrete high levels of VEGF (Katz et al, 2005), 
again making the pairing of ASCs and fibrinogen highly synergistic. As VEGF, TGF-ß1, and 
PDGF are normally linked to wound healing but are absent in purified fibrinogen or fibrin glue 
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as supplied, using ASCs to secrete these factors into scaffolds or wounds may be yet another 
advantage to our cellular approach.  
Structurally, fibrinogen molecules are composed of two matched sets of disulfide-bridged 
α-, ß-, and γ-chains, each with two outer D domains connected by a coiled-coil segment to a 
central E domain. Fibrin forms from fibrinogen in the coagulation cascade process, where the 
zymogen prothrombin is activated to the serine protease thrombin, which cleaves fibrinopeptide 
A from the fibrinogen α-chain, thereby inducing fibrin polymerization. Fibrin is then cross-
linked by factor XIII, forming a clot. Factor XIIIa further stabilized fibrin, incorporating the 
fibrinolysis inhibitors alpha-2-antiplasmin and thrombin activatable fibrinolysis inhibitor 
procarboxypeptidase B (TAFI). TAFI further allowing for the binding of several cell adhesive 
proteins (Mosesson, 2005). 
Fibrinogen has the advantage of being an autologous matrix, that can be purified in as 
little as 20 minutes in a minimally-equipped lab or hospital setting, needing only a centrifuge, 
freezers, and cryoseal bags (Valbonesi, 2004). It is a rare patient-derivable scaffold source. 
Additionally, fibrin glue and fibrin gel-related products have been approved for clinical use in 
concert with mesenchymal stem cells. For instance, MSC implants are coupled with autologous 
fibrin-platelet glue in maxillofacial surgery to promote wound healing and bone regeneration 
(Giannini et al., 2004), creating bioengineered ocular surfaces for corneal epithelial stem cells to 
differentiate upon (Han et al., 2002) and form a dermal matrix with live fibroblasts for skin grafts 
(Meane et al., 1998). 
Lastly, fibrinogen has been shown to be amenable to the electrospinning process 
(Matthews et al., 2002, McManus et al., 2007) to form a biomimetic, biocompatible, and 
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biodegradable matrix for tissue engineering applications. The ability to readily modify the 
average fiber diameters of electrospun fibrinogen to mimic the biologic fibrinogen fiber range of 
a few hundred nanometers (Table 2), depending on clot architecture (Collet et al., 2000; Moen et 
all, 2003), further makes it an excellent starting material for tissue engineering. 
 
 
MATERIAL SELECTION: Polydioxanone 
Polydioxanone (PDO) is a crystalline, colorless biodegradable poly(ether-ester) polymer 
exhibiting good flexibility and mild shape memory. PDO is formed through ring opening of p-
dioxanone monomers by heat and an organometallic catalyst (such as diethylzine, zinc L-lactate, 
or zirconium acetylacetone) to form polydioxanone polymers (Figure 3). PDO has been applied 
for many biomedical uses including orthopedics, cardiovascular and plastic surgery applications, 
and drug delivery. Most notably, PDO is extruded into fibers for a degradable suture material, 
one that loses half of its mechanical strength in about 20 days in vivo, yet can take up to 6 
months to fully degrade. 
PDO has the distinct advantage of exhibiting a low inflammatory response compared to 
other polymers used in sutures (Wainstein et al., 1997). Though it has many biological benefits 
as a suture material, PDO retains shape memory, a major drawback for the suture application. 
The shape memory may, however, prove a valuable mechanical property in engineering tissue 
scaffolds, as has been proposed (Boland et al., 2005). Along with its biocompatibility, the 
absence of an immune response, and its ability for simple degradation by hydrolysis into safe 
byproducts make it an ideal candidate for tissue engineering and in many ways possibly superior 
to competing synthetic materials (Molea et al., 2000). Additionally, our work has shown that  
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Table 2: Average Fiber Diameter and Pore Size of Native/Uncross-linked 
Electrospun Fibrinogen Scaffolds# 
 
#(adapted from McManus et al, 2006) 
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Figure 3. Polymerization Reaction of p-dioxanone to Polydioxanone. The chemical transition 
of p-dioxanone, through addition of heat and a catalyst, to the polydioxanone polymer is shown. 
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electrospinning of PDO produces micron to submicron diameter fibers, and it will readily co- 
electrospin with fibrinogen, collagen, and other natural matrix materials, again making it a 
suitable polymer for tissue engineering applications. Blending natural matrices with a synthetic, 
like PDO, has the advantage of alleviating the need for additional chemical cross-linking to 
prevent gelling or to slow dissociation of the natural polymer, as the blending itself stabilizes the 
electrospun mesh. 
 
MATERIAL SELECTION: Adipose Extracellular Matrix 
Adipose tissue is extracellular matrix-rich, densely composed of collagens Type I, III, IV, 
V, and VI, laminin, and fibronectin (Nakajima et al., 1998). In fact, the amounts of these proteins 
have been shown to match or exceed the levels of ECMs in tissues known to be rich in such 
materials, such as capillaries, arteries, and perimysium from skeletal muscle (Table 3). 
Interestingly, using radiolabeled antibodies, investigators have shown that adipose cell 
precursors that differentiated into mature adipocytes in vitro heavily secrete collagens Type I, III, 
IV, V and VI, laminin, and fibronectin. These pre-adipocytes cultured in adipogenic 
differentiation media show an 8- to 15-fold upregulation in deposition of ECM materials in the 
extracellular spaces compared to the same cells cultured in normal growth media (Nakajima et 
al., 2002). 
Incidentally, the ECM composition of Matrigel (BD Biosciences), a highly important 
mixed matrix derived from mouse sarcomas that has been shown to be crucial for supporting 
pluripotent stem cells and a wide array of other cell types, is comprised of 56% laminin, 31% 
collagen type IV, and 8% entactin. Furthermore, Matrigel (not growth factor reduced) contains 
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Table 3: Quantification of ECM Proteins from Dissected Skeletal Tissue, 
Matrigel and Adipose Tissue# 
                  Capillaries and         
ECM proteins  Adipose Tissue        Small arteries    Matrigel    
Type I Collagen  +       +           -    
Type II Collagen             low      low         low             
Type III Collagen  +      low           -               
Type IV Collagen  +      low           +   
Type V Collagen  +      low           -    
Type VI Collagen  +       +           -    
Elastin    +       +           -   
Fibronectin   +       +         low             
Laminin   +       +           +    
Proteoglycans,                                    
    Glycosoaminoglycans 
    & Glycoprotein  +       +           + 
#Adapted from Nakajima et al. 1998 and BD Bioscience product sheet data. 
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 relatively high levels of EGF (1.3ng/ml), TGF-ß (2.3ng/ml), and PDGF (12pg/ml) with trace 
amounts of bFGF (0.1pg/ml), all of which are secreted by ASCs and can strongly bind the ECM 
molecules of adipose tissue. Because mouse-derived Matrigel has limits on its application 
clinically, derivation of a highly analogous ECM from human fat tissue has far reaching 
implications for translating a number of studies using Matrigel to potential clinical models. 
Along with fibrinogen, and due to its extraordinary matrix composition, adipose tissue 
ECM may also prove to be a highly ideal, patient-derivable scaffolding source material for 
regenerative medicine and basic stem cell biology research. Currently, no established protocols 
exist for harvesting fat ECM from patient-derivable liposuction in quantities suitable for 
regenerative medicine applications. Moreover, fat ECMs have only been scarcely referenced and 
rarely studied in the field. Classic ECM papers of the 1940’s through the 1970’s set no precedent 
for fat ECM extraction, and, in fact, within their initial steps, ECM extraction protocols usually 
direct one to carefully remove all fat from the target tissue for discard (Haralson and Hassell, 
1995). Needless to say, adipose tissue matrix has yet to be tested as a viable matrix for 
electrospinning, likely due to the absence of a suitable extraction methodology. While it is 
widely accepted that a biomimetic and autologous matrix source is therapeutically ideal, a 
plentiful autologous matrix source is still lacking. Because it is readily patient-derived and has 
rich matrix composition with high biological activity, adipose tissue matrix, along with plasma 
borne fibrinogen, may prove to be invaluable autologous matrix materials. 
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Study Rationale 
 
With the ability to regenerate bone potentially having undergone 560 million years of 
refinement in vertebrates, it seems logical to look to nature for guidance in generating bone cells 
and bone tissue analogues for clinical and basic science needs. Given that a primordial matrix of 
fibrinogen forms in damaged bone leading to the recruitment of mesenchymal stem cell 
progenitors for subsequent stages of regeneration, we have chosen fibrinogen and adipose-
derived mesenchymal stem cells as our starting template for modeling osteoblastogenesis ex 
vivo. While bone marrow-derived MSCs are also an excellent cell source, ASCs have shown 
distinct advantages over BM-MSCs; most notably that they are easily accessibility, very 
abundant with a stem cell pool well beyond the numbers of cells isolated for BM-MSCs, are 
capable of robust osteoblastogenesis and have a proven clinical record.  
While collagen type I may be an excellent material for modeling and stimulating 
osteoblastogenesis, with type I collagen being the native and predominant ECM of mature bone, 
collagen is typically only available from rat-tails or bovine sources, which are problematic 
therapeutically. Human collagen, which would be far less immunoreactive, is not readily 
available or cost effective, and autologous collagen I is not currently harvested in large quantities 
without extreme patient morbidity associated with removing significant amounts of skin. 
Fibrinogen, however, can be readily harvested from the patient through simple blood collection 
and is potentially available in large quantities through blood/plasma clinics, as fibrinogen is 
generally removed from donated blood/plasma prior to use and than is ultimately discarded. 
Additionally, liposuction material rich in basement membrane ECM is discarded, and this ECM 
can be readily isolated for therapeutic and basic research use. Thus, the potential exists for the 
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use of frequently discarded medical waste that can be appropriately applied to regenerative 
medicine.  
While many techniques for forming a biomimetic tissue scaffold exist for regenerative 
medicine apart from electrospinning, few approaches produce scaffolds with fibers rather then 
sheets and even fewer produce biologically relevant nanoscale fibers. Only electrospinning offers 
an elegant, affordable, and diverse method for creating nanofibrous scaffolds with modifiable 
mechanical properties and the mixed material composition needed for a wide array of tissue 
engineering needs. 
In this study, we explore the potential of biomimetic and exclusively patient-derived 
regenerative matrices generated via the electrospinning of fibrinogen and adipose ECM as a 
substrate for ASC growth and differentiation. We hypothesize that electrospun fibrinogen 
nanofibers, alone or blended with PDO, are capable of supporting stem cell attachment, 
proliferation, and osteoblastogenic differentiation, thereby forming a mineralized scaffold 
containing cells expressing osteoblast-specific markers and proteins. Further, we hypothesize 
that a basement membrane-rich ECM can be derived from human adipose tissue that can: 1) be 
electrospun in its pure form; 2) be blended with a synthetic material, PDO, and then electrospun; 
3) maintain its material composition through the electrospinning processing; and 4) support the 
attachment and cultivation of ASCs. These tissue generation and original scaffold material 
derivation experiments will lay a foundation for a wide range of uses in regenerative medicine, 
cell biology, cancer research, and other applications, whereby the natural healing process can be 
more thoroughly studied in vitro. The tools discovered here may further prove useful for 
developing better therapies for wound healing and safer drug development, while potentially 
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being used as a model for creating better artificial tissues ex vivo by following the recipes 
supplied by nature. 
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-Chapter 2- 
Results: Isolating Adipose-Derived Mesenchymal Stem Cells from 
Lipoaspirate Blood and Saline Fraction 
 
Preface: The following section has been published in Organogenesis, January 2010, Vol. 6, 
Issue 1, 10-14. 
 
 
 
 
 
 
ABSTRACT 
Isolation of adipose-derived stem cells (ASCs) typically involves 8+ hours of intense effort, 
requiring specialized equipment and reagents. Here, we present an improved technique for 
isolating viable populations of mesenchymal stem cells from lipoaspirate saline fractions within 
30 minutes. Importantly, the cells exhibit remarkable similarities to those obtained using the 
traditional isolation protocols, in terms of their multipotent differentiation potential and 
immunophenotype. Reducing the acquisition time of ASCs is critical for advancing regenerative 
medicine therapeutics, and our approach provides rapid and simple techniques for enhanced 
isolation and expansion of patient-derived mesenchymal stem cells. 
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INTRODUCTION 
The original, pioneering work on the isolation of adipose-derived stem cells (ASCs) from 
liposuction waste involves 8-10 hours of continuous intense effort (Zuk et al. 2001; 2002), 
making it a labor-intensive endeavor and increasing the risk of culture contaminations due to 
excessive handling. Based on recent reports (Crisan et al., 2008), we originally postulated that 
the blood/saline portion of lipoaspirate waste would prove to be a rich source of ASCs due to 
their association with the perivascular space. In addition, because of the violent nature of 
liposuction and the ultrasonic procedure used to obtain these samples, we expected to find 
significant number of ASCs in the blood and saline fractions of the lipoaspirate waste. 
We present an enhanced method for isolating and quickly expanding a robust population 
of mesenchymal stem cells (MSCs) derived from lipoaspirate in less than 30 minutes. This 
isolation process yields an abundant population of ASCs (~100,000 cells per 100ml of 
blood/saline collected from sonicated lipoaspirate) with differentiation potential, characteristic 
cell surface markers, and proliferative lifespan indistinguishable from MSCs extracted from bone 
marrow (BM-MSCs) or conventionally processed ASCs (Zuk et al., 2001; 2002). 
 
RESULTS 
As outlined in Fig. 4, a viable population of adherent ASCs is easily obtained from the 
blood and saline phase that carries over with liposuction surgical refuse. This layer is located 
below the floating, more buoyant adipose tissue and is processed though a simple 5-step process. 
First, the blood/saline phase is isolated and cells pelleted (10 minutes). Second, the resulting 
pellet is gently re-suspended in NH4Cl for red blood cell lysis (2-5 minutes). Third, the cells are  
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Rapid Isolation
Aspirate ~250ml blood/saline into
50ml conical tubes
Centrifuge at 400xg for 10min at RT
Resuspend pellet in 160mM NH4Cl
for 5min at RT
Centrifuge at 400xg for 10min at RT
Gently resuspend pellet in DMEM,
40% FBS and plate
Wash non -adherent cells from
plastic next day
Rapid Isolation
Duration : ~30 minutes
Yield: ~2.5x10 5 cells
Materials Required:
Centrifuge, NH4Cl , DMEM, 
FBS, ABAM
Standard Isolation
Aspirate off saline and oil phases
Wash ~250ml fat 3 -5 times for
5min each in PBS, discarding
lower phase until clear
Add collagenase in PBS and incubate 
on a shaker at 37C for 1 -4hrs
Add 10% FBS to neutralize collagenase
Centrifuge digested fat in 50ml tubes
800xg for 10min
Aspirate floating adipocytes , lipids
and liquid, leaving SVF pellet
Resuspend SVF in 160mM NH
4
Cl;
incubate 10min at RT
Centrifuge 400xg for 10min at RT
Layer cells on Percoll or
Histopaque gradient
Centrifuge 30min at 1000xg in at RT
Wash gradient -separated cells 2x
in PBS with 400xg for 10min
spins between washes
Resuspend pellet in PBS; filter
through 100 µM nylon mesh
Pass cells through 40 µM mesh
Spin 10min at 400xg
Resuspend pellet in DMEM,
40% FBS & plate
Wash non -adherent cells from
plastic the next day
Standard Isolation
Duration: 8-10+ hours
Yield : ~2x10 6 cells
Materials Required:
Large Heated Shaker, Fixed bucket 
Centrifuge, Swing -out bucket 
Centrifuge, NH4Cl, PBS, DMEM, FBS, 
Collagenase A IV, Percoll or Histopaque
cell density gradient , 100 µM nylon 
mesh, 40 µm nylon mesh, ABAM
{
}
 
Figure 4. Adipose-Derived Stem Cell Isolation Techniques Flow Chart. The wide variance in 
the time, materials, and effort for obtaining ASCs via the Standard Isolation and our Rapid 
Isolation techniques is shown. A highly viable population of around 250,000 ASCs can be 
derived from 250ml of blood/saline fraction of the liposuction waste in as little as 30 minutes, as 
compared to 8-10 hours to obtain ASCs using the traditional isolation method. SVF – stromal 
vascular fraction; ABAM – antibiotic/antimycotic, FBS – fetal bovine serum.  
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pelleted again (10 minutes). Fourth, the cell pellet is gently re-suspended in DMEM with 40-50% 
fetal bovine serum (FBS), followed by plating the cells (2-5 minutes) and incubation overnight. 
Finally, the non-adherent cells and debris are washed away with phosphate-buffered saline 
(PBS), and the 30 minute ASC cultures are grown. This isolation method not only requires less 
than half an hour to complete but uses only standard tissue culture materials and equipment 
without the need for collagenase digestion, Percoll gradients, or extensive washing. Use of this 
isolation technique allows for the straightforward establishment of both patient-specific ASCs 
for regenerative medicine and disease-specific cell strains for scientific discovery.  
Beyond sharing a mesenchymal morphology with other MSCs, the ASCs isolated in this 
streamlined manner were shown to share multipotent differentiation potential and an 
immunophenotype with the traditionally isolated ASCs (shown in Figure 5A-I for 
differentiation, Table 3 for flow cytometry, performed as reported previously, Zuk et al., 2001; 
2002; Katz et al., 2005), characteristics that are also indistinguishable from BM-MSCs (not 
shown). Rapidly isolated ASCs have a CD14-, CD29+,CD31-, CD34low/+, CD45-, CD73+ and 
CD105+ immunophenotype (Table 3), consistent with classically isolated ASCs (Table 3) and 
BM-MSCs (not shown). In agreement with previous reports on ASCs and BM-MSCs (Zuk et al., 
2001; 2002; Izadpanah et al., 2005; Kern et al., 2006; Yoshimura et al., 2006), rapidly isolated 
ASCs also have undetectable levels of telomerase, as assessed either by a TRAP assay or RT-
PCR for the catalytic subunit of telomerase, hTERT (not shown). Because rapidly isolated ASCs 
are nearly identical to both BM-MSCs and ASCs isolated in the traditional long protocol in terms 
of important MSC characteristics, ASCs isolated using our accelerated protocol warrant the same 
adult stem cell classification.  
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& Stained
Adipogenesis Osteogenesis Chondrogenesis
 
Figure 5. Characterization of ASC Differentiation. The differentiation potential of ASCs 
isolated in the streamlined, rapid protocol were compared to ASCs isolated using the standard 
protocol (traditional ASCs). Cells were induced to differentiate into adipocytes (A) for rapid 
ASCs and (G) for traditional ASCs; (D) rapid ASCs grown for 2 weeks without adipogenic 
media as control; all stained with oil red O and hematoxylin), osteocytes (B) for rapid ASCs and 
(H) for traditional ASCs; (E) rapid ASCs grown 2 weeks without osteocyte induction media as 
control; all stained with Alizarin red S and hematoxylin, and chondrocytes (C) for rapid ASCs 
and (I) for traditional ASCs, both in a micromass (solid micromass pellet, insert, (C); (F) 
unpelleted rapid ASCs grown 4 weeks in induction media as control; all samples stained for 
Safranin O.  
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Table 4: Immunophenotype of ASCs Isolated using the Rapid and Standard Protocols  
Cell Type CD14 CD29 CD31 CD34 CD45 CD73 CD105 
Rapid ASCs - + - low - + + 
Traditional ASCs - + - low - + + 
HL60 (controls) + nt + nt + nt nt 
  nt = not tested. 
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We also show that the addition of epidermal growth factor (EGF) to the regular ASC 
growth media elicits a marked enhancement to the proliferation rate for ASCs with no effects on 
proliferative lifespan or differentiation potential (Table 5). ASC cultures supplemented with 
EGF show a sharp increase in proliferation rate and an increased senescence population doubling 
(PD) timing compared to unsupplemented ASCs (Table 5). With EGF added to normal growth 
sera, doubling times, as measured over a 120 day span, were calculated at 28 hours for EGF 
supplemented cells, compared to 65 hours for unsupplemented cells. Importantly, EGF-ASCs 
still undergo robust differentiation and appear otherwise unchanged compared to ASCs under 
standard conditions, apart from the enhanced proliferation rate and increased senescence timing, 
which is consistent with a recent report suggesting ASCs have functional EGF receptors (Baer et 
al., 2009). 
We have detailed a simple, rapid, and effective method for isolating adipose-derived stem 
cells from the blood/saline fraction of lipoaspirates. These ASCs exhibit somatic progenitor (i.e. 
stem cell traits) and phenotypic properties indistinguishable from ASCs isolated using the labor-
intensive traditional protocol and the gold-standard BM-MSC. We have also observed that EGF 
supplementation increases proliferation rates of ASC cultures. Thus, the methods described here 
mutually facilitate the autologous stem cell extraction process and the ability to generate a large 
number of cells, both of which have been longstanding hurdles for basic regenerative medicine 
research and therapeutics.  
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Table 5: EGF Supplemented ASC Media Enhances Growth 
Cell Type Growth Rate (PD/week)* Avg. Senescence PD 
ASCs (-EGF)# 2.58 38.5 
ASCs (+EGF) 6.05 46.5 
*PD – population doubling 
#EGF – epidermal growth factor 
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METHODS 
Traditional and Rapid ASC isolation 
ASC isolation was carried out as previously described with slight variations (Zuk et al., 2002). 
Briefly, oil from the top of the lipoaspirate was immediately removed from freshly harvested fat, 
followed by the isolation of the saline/blood fraction (see Figure 4). For the traditional isolation, 
200ml aliquots of fat were washed 3-4 times with equal volume PBS and incubated in 50% 
volume 150µg/mL collagenase (Sigma-Aldrich) with 1% ABAM (Invitrogen) for 60min at 37°C 
shaking at 250rpm. Collagenase was inactivated with 10% FBS, followed by redistribution of 
mixture into 50ml conicals and centrifugation at 1000xg for 10min to separate the oil and 
remaining fat lobules from the stromal vascular fraction (SVF). The pelleted SVF was treated 
with 160mM NH4Cl at room temperature for 10min to lyse red blood cells, and applied to a 
Percoll gradient (Sigma-Aldrich) to purify the mononucleated cells.   
The rapid isolation protocol involves multiple steps at room temperature including 
centrifugation of the saline/blood fraction at 400xg for 10min, followed by red blood cell lysis 
with 160mM NH4Cl for 5min, and a final centrifugation for 10min at 400xg.  
For both traditional and rapid protocols, the final pelleted fraction of mononuclear cells 
was then resuspended in 25ml DMEM:F12 media (Invitrogen) supplemented with 40% FBS 
(Invitrogen), ABAM, and 10ng/mL EGF (BD Biosciences) incubated overnight to select for 
adherent cells. The remaining floating cells were aspirated off the following day, and the plate 
was washed with PBS to remove any remaining debris. ASCs were maintained on DMEM low 
glucose supplemented with 10% FBS, 1% ABAM, with or without 10ng/ml EGF at 5% CO2 at 
   
 44 
37°C. For quantification of growth, cells were maintained on 100mm dishes and split at 
confluence at a ratio of 1:4 until a senescent state was achieved.   
 
Osteocyte Differentiation 
Cells are plated and grown until approximately 75% confluent, followed by osteogenic 
differentiation in DMEM with high glucose, 10% FBS, 0.01µm 1.25-dihydroxyvitamin D3 
(Sigma-Aldrich), 50µm ascobate-2-phosphate (Sigma-Aldrich), 10mM β-glycerophosphate 
(Sigma-Aldrich), and 1% ABAM.  The cells were cultured for 2 weeks and then washed and 
fixed in 4% paraformaldhyde.  The cells were then stained using Alizarin Red S (Sigma-
Aldrich), which specifically stains calcium deposits, and whole field light microscopy images 
were then captured at 10x. 
 
Adipocyte Differentiation 
Cells that were fully confluent were treated with adipogenic media containing DMEM low 
glucose, 10% FBS, 0.5mM isobutyl-methylxanthine (Sigma-Aldrich), 1µM dexamethasone 
(Sigma-Aldrich), 10µM insulin, 200µM indomethacin (Sigma-Aldrich), and 1% ABAM.  The 
plates were maintained for 2 weeks until lipid droplet formation was observed, followed by 
fixation in 4% paraformaldehyde. Fixed cells were stained with Oil Red O (Sigma-Aldrich), 
which specifically stains lipid droplets, and whole field light microscopy images where captured 
at 10x. 
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Chondrocyte Differentiation 
At total of 2 x 105 cells were pelleted in a 2ml V bottomed tube and placed in the incubator at 
37°C with 10% CO2 in chondrogenic media, which contained DMEM low glucose, 1% FBS, 
6.25µg/ml insulin, 10ng/ml recombinant TGFβ3 (R&D Systems), 50nM ascorbate-2-phosphate, 
and 1% ABAM.  After 1 week, the pellets were transferred to a 10 cm dish and cultured in the 
same media formulation for another 2wks.  The pellets were fixed in 4% paraformaldehyde and 
stained with Safranin O (Sigma-Aldrich), which specifically stains GAG proteins present in 
chondrocyte extracellular matrix.  The micromass pellets were imaged with a 1mm scale bar to 
indicate gross anatomy and size. 
 
Flow Cytometry 
Both traditional and rapid ASCs were trypsinized and counted in order to obtain 5 x 105 cells for 
primary antibody or 2 x 105 cells for secondary antibody only and no antibody controls.  These 
cells were centrifuged at 100xG for 1min at 4°C and resuspended in 75µl of FACS buffer (PBS, 
2% FBS) and incubated on ice for 10 minutes.  The primary antibody was added (CD14, CD29, 
CD34, CD45, CD73, CD105, InVitrogen; CD34, Millipore, 100mg/ml) and incubated with 
rotation at 4°C for 30min, followed by centrifugation and 3 washes with FACS buffer.  The 
secondary antibody (Alexa 488 goat anti-mouse; Invitrogen)) was then added at a dilution of 
1:400 and incubated in the dark at 4°C with rotation for 30min. The washes were then repeated, 
and the resulting pellet was resuspended in 500µl PBS and forced through a 35µm mesh filter to 
remove any cell clumps. Immunolabeled cell suspensions were kept on ice until cytometric 
analysis, which was performed using a Coulter Epics XL-MCL.
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-Chapter 3- 
Results: Electrospinning Adipose Tissue-Derived Basement 
Membrane for Stem Cell Culture and Regenerative  
Medicine Applications 
 
ABSTRACT: 
We describe a robust method for purifying the extracellular matrix (ECM) from adipose tissue 
and the use of this adipose tissue ECM (At-ECM) for electrospinning and adipose stem cell 
(ASC) culture. The matrix composition of this purified and electrospun adipose tissue ECM was 
assessed histochemically, showing basement membrane, connective tissue, collagen elastic 
fibers/elastin, glycoprotein and proteoglycans staining. Each of the histochemical stains was 
positive for fat tissue, purified fat ECM, and for electrospun fat ECM samples, while staining 
slightly positive blended with a synthetic biomaterial, polydioxanone (PDO). Protein analysis 
also revealed the presence of collagen type I in purified adipose tissue ECM. Immunolabeling for 
collagen type IV directly indicated its presence in fat tissue, in purified fat ECM, and in 
electrospun fat ECMs. We also assessed the ability of electrospun adipose ECM, alone and 
blended with polydioxanone (PDO), for supporting adipose stem cell attachment and growth, 
showing that electrospun adipose ECM scaffolds fully support the cultivation of ASCs. These 
studies show for the first time that adipose ECM can be isolated and electrospun as a tissue 
engineering matrix capable of supporting stem cells, providing the groundwork for an array of 
future regenerative medicine advancements. 
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INTRODUCTION: 
Originally thought of as merely the structural component for cell and tissue support, 
extracellular matrix (ECM) has been established as being important throughout biology. Four 
major classes of macromolecules—collagens, structural glycoproteins, proteoglycans, and 
elastin—collectively comprise the ECM of animal cells, being both widely distributed and 
multifunctional throughout the body (Table 1) (Palsson et al., 2004). ECM is constantly 
synthesized, secreted, oriented, and modified by the cellular components that they support. 
Members of each family and class of ECM molecules exhibit a degree of tissue-specific 
distribution, implicating the ECM in development and tissue function. Additionally, specific cell 
surface receptors have been identified on ECM components, linking the biology of the cell with 
its ECM interactions.  
Throughout embryonic and fetal development, ECM interactions orchestrate such 
activities as cell migration and proliferation, stem cell differentiation, tissue patterning, and 
morphogenesis (Campbell et al., 1985; Flaim et al., 2005; Haylock et al., 2005; Kihara et al., 
2006; Suzuki et al., 2003). The ECM interacts directly with cell surface receptors, acting as a 
reservoir for growth factors and morphogenetic proteins, as well as simply providing a scaffold 
for cell attachment and cell migration. Even cell morphology is determined by contact with the 
ECM, which may be associated with cell differentiation and proliferation. For example, floating 
type I collagen gels can induce functional differentiation of precursor cells into mammary 
glands, mediated through changes in cell shape, allowing branching morphogenesis to occur 
(Bissell et al., 1987). Further, laminin-I is expressed in developing mouse lung by epithelial and 
mesenchymal cells, where it is essential for branching morphogenesis (Schuger et al., 1991).  
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Basement membranes are common to tissues of nearly all multicellular metazoans, and 
their gene products are highly conserved and are among the most ancient in nature (Exposito et 
at., 2002, Hutter et al., 2000). Basement membrane (or basal laminae) proteins are the first ECM 
materials to appear during embryogenesis, with laminin being the first detectable ECM protein 
that appears shortly after morula differentiation (Martin and Timpl, 1987; Miner and Yurchenco, 
2004). Throughout development of the embryo and fetus, basement membrane and other ECM 
materials assemble in nearly all tissues, having a profound effect on their developmental fate. 
Loss of phenotype studies in C. elegans have shown that several basement membrane 
components, including type IV collagen, laminin, and perlecan, are necessary for tissue 
organization and structural integrity, and essential for the completion of embryogenesis (Kramer, 
2005). 
While the basal laminae has proven to be an important ECM throughout biology, a 
suitable human source of this basement membrane ECM, especially engineered as biomimetic 
nanofibers, has been sorely lacking. If a basement membrane analogue of human origin could be 
derived and engineered with biologically relevant fibers sizes, there exist many potential 
applications for this material in basic research and clinical therpies. 
A material of human origin that could possibly take the place of commonly used 
xenogenic basement membranes in research, such as Matrigel®, which would have great 
potential for rapid clinical translation, is autologous adipose tissue ECM (At-ECM). Adipose is 
an extracellular matrix-rich tissue densely composed of collagens Type I, III, IV, V, and VI, 
laminin, and fibronectin (Nakajima et al., 1998). In fact, the amounts of these proteins have been 
shown to match or exceed the levels of ECMs from tissues known to be rich in such materials, 
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such as the perimysium from skeletal muscle (Nakajima et al., 2005, Abberton et al., 2008). 
Interestingly, recent studies have shown that adipose cell precursors differentiated into mature 
adipocytes heavily secrete collagens Type I, III, IV, V, and VI, laminin, and fibronectin in vitro. 
These preadipocytes cultured in adipogenic differentiation media exhibit an 8- to 15-fold 
upregulation in deposition of these ECM materials in the extracellular spaces when compared to 
the same cells cultured in normal growth media (Nakajima et al., 2002). 
Markedly few established protocols exist for harvesting purified fat ECM from patient-
derivable liposuction in quantities suitable for regenerative medicine applications (Haaralson et 
al., 1995). Moreover, as fat ECMs have only been scarcely referenced and rarely studied in the 
field, it is not surprising that adipose tissue has yet to be tested for its ability to be electrospun 
into a nanofibrous tissue engineer matrix.  
The electrospinning technique for bio-scaffold construction has rapidly gained favor in 
the tissue-engineering field due to its numerous advantages over conventional scaffold 
fabrication methods (Barnes et al., 2007). Electrospinning involves maintaining a polymer 
solution at the tip of a needle at its surface tension by way of a syringe pump. As sufficiently 
high voltage is passed through the needle, the polymer’s outer layers receive a charge, pulling 
them from the needle and towards a grounded collection through the electric field. As the 
polymer leaves the needle, the solvent evaporates, leaving dry polymer fibers for collection. 
Natural matrix materials, such as collagen, laminin, elastin, and fibrinogen, and synthetic 
materials such as the suture material polydioxanone (PDO), can be electrospun into scaffolds of 
numerous shapes and microscopic properties, resembling native extracellular matrices in 
geometry, fiber size, and material composition (Barnes et al., 2007, Matthews et al., 2002; Wnek 
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et al., 2003; McManus et al., 2007; Boland et al., 2005). While conventional polymer processing 
techniques generally create fibers 10µm or larger in diameter, the nanofibers generated from 
electrospinning are capable of mimicking the sub-micron diameter and geometry typical of 
endogenous tissues. 
While it is widely accepted that a biomimetic, autologous matrix supply is therapeutically 
desirable, an abundant source for regenerative medicine applications is still lacking. We show 
that adipose tissue ECM (At-ECM) is a valuable autologous ECM material, one that can be 
procured from a readily accessible source and is amenable to the electrospinning process. This 
newly synthesized material produces biomimetic nanofibrous scaffolds that are rich in basement 
membrane components that are further capable of supporting ASCs. 
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MATERIALS AND METHODS: 
 
Adipose Stem Cell Primary Isolation and Culture 
In accordance with Virginia Commonwealth University’s IRB, lipoaspirate was obtained 
as surgical waste from patients undergoing elective, cosmetic surgery using standard techniques, 
and characterized as described previously (Francis et al., 1010, Zuk et al., 2001; Zuk et al., 
2002). The cells were cultured in low glucose DMEM (Gibco) with 10% FBS (Hyclone), 10nM 
recombinant human EGF (Sigma), and 1% ABAM, and maintained at 37°C with 5% CO2. Cells 
were verified to be multipotent and to exhibit a mesenchymal stem cell immunophenotype as we 
previously reported (Francis et al., 2010). 
 
Microscopy 
 To determine scaffold topography and fiber diameter of electrospun adipose tissue ECM 
scaffolds, SEM was performed. Constructs were fixed in gluteraldehyde and processed by 
standard methods in the VCU Microscopy Core (Crawford et al., 2004). Samples were then gold 
sputter coated and analyzed by a Zeiss EVO 50 XVP (Nano Technology System Division, Carl 
Zeiss), with images taken at 20kV, and at least 3 representative fields captured for evaluation. 
For fluorescent microscopy visualizing of ASCs grown of electrospun At-ECM, scaffolds were 
stained with 4’,6-diamidino-2-phenylindole (DAPI) and mounted in Vectashield (Vector Lab H-
1000). An Olympus IX70 inverted fluorescent microscope was used for capturing phase and 
fluorescent images using QCapture Pro software  (QImaging). 
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Adipose Tissue ECM Extraction 
All steps were performed at 4ºC to maintain matrix integrity and prevent enzymatic 
digestion of the adipose tissue extracellular matrix (At-ECM). Around 200ml of lipoaspirate 
(n=16) was washed extensively in cold PBS to remove contaminating red blood cells and 
enzymes. The washed lipoaspirate was cycled through extensive freeze-thaw cycles with liquid 
nitrogen and a RT water bath. The upper oil/lipid phase from lysed adipocytes was drawn off, 
and the processed stromal tissue was then thoroughly digested in 20x volumes of 0.5M acetic 
acid at pH 2.5 for 48-72hrs with vigorous stirring, and tested with or without a 1:10 diluted 
pepsin (Sigma)-to-ECM blend. Remaining undigested floating tissue (albeit minimal) was 
filtered out with cheesecloth. The digested matrix was centrifuged at 8,000 x g for 10min and the 
undigested tissue pellet discarded and any remaining oil drawn off. The opaque supernatant was 
dialyzed 3 times in 12-14,000MW dialysis tubing against 0.5M acetic acid changed daily, then 
against 3 daily changes of pure deionized water. The resulting opaque and condensed matrix 
within the dialysis tubing was frozen at -80ºC and minimally lyophilized, with the resulting 
yellowish, fluffy matrix material weighed and stored at -20ºC. Samples were tested for solubility 
in organic solvent (1,1,1,3,3,3-hexaflouro-2-propanol, HFP, or triflouroacetic acid, TFA, Sigma 
or TCI America, Portland, OR). If procured At-ECM was not soluble in HFP or TFA, they were 
re-dissolved in 0.5M glacial acetic acid with a repeat of the dialysis process as above, again with 
only the minimal amount of lyophilization to prevent undue crosslinking. The samples are then 
and rechecked for solubility. 
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Electrospinning Adipose ECM 
Separately, 60, 80, 100, 120 and 140mg/ml of adipose matrix material were dissolved in 
HFP or TFA organic solvents for roughly 15min with mixing, and then electrospun either as pure 
At-ECM, or a 1:10 At-ECM:PDO blend at 100mg/ml in HFP. The opaque solution was then 
loaded into a 5ml (Becton-Dickinson) plastic syringe with a blunt tipped 18.5ga needle and 
placed into a syringe pump (KD Scientific) set at 2.5ml/hr. A 0.3mm X 10mm X 2mm 
rectangular receiver mandrel was situated 12cm from the needle and set to spin at 650RPM with 
a 2cm/s translation speed over 7.2cm total travel. The anode from a Spellman CZE1000R high 
voltage power supply was clipped to the needle for generating a +25kV field, with the mandrel 
being charged at -5kV with a second amplifier. Pure At-ECM scaffolds were tested with and 
without cross-linking for 72h at RT in 30mM genipin (Sell et al., 2008) for stability and gelling 
in warm media for 7 days. 
 
Scaffold Seeding and Tissue Culture 
For static seeding, scaffold discs 10mm in diameter were formed with tissue biopsy 
punches from At-ECM and At-ECM:PDO sheet made at 80-100mg/ml concentrations and placed 
in 48-well plate. Scaffolds were disinfected with 80% ethanol for 30min, and then washed 3 
times for 5min in PBS. Cells to be seeded upon the discs were concentrated to 25,000 
cells/100µl, and a single 100µl drop of cells was careful placed on the center of the disc. Cells 
were allowed to adhere in the incubator for 15min and then 500µl of media was then added. 
Media was carefully aspirated every 3-4 days and replaced with fresh media. The discs were 
collected at days 1 and 14 for analysis. 
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Histological Scaffold Evaluation 
Scaffolds were washed in PBS and fixed in 10% formalin, then paraffin embedded, 
cryosectioned, and mounted on slides for standard histological staining and 
immunohistochemistry (IHC) at the Anatomic Pathology Laboratory Research Services at VCU. 
Using a Dako Artisan Staining System X automated system, scaffolds were evaluated for Jones 
(basement membrane), Mason’s (collagen), Gomori (connective tissue/collagen), Periodic Acid-
Schiff (glycogen, proteoglycans and glycoproteins), Verhoeff-Von Gieson (elastic fibers/elastin) 
and H&E staining.  
Paraffin embedded scaffold were also sectioned and mounted on slides for IHC using 
standard techniques. Immunohistochemistry (IHC) was performed on control placental, kidney 
or liver sections, as well as on an abdominoplasty section of human fat, or purified At-ECM, of 
electrospun At-ECM, and a 10% At-ECM 90% PDO blended electrospun scaffold. 
Deparafinized slides were blocked with PBS containing 1% BSA for 60 min at RT. A 300µg/ml 
aliquot of the collagen type IV monoclonal antibody (Abcam) was diluted in PBS with 1% BSA 
and one drop was applied to each section, with the slides placed in a humidified chamber 
overnight at 4°C. The slides were then washed 5X over 50 min in PBS with 1% BSA, followed 
by immersion in Peroxidase Suppressor (Pierce) for 30 min at RT, followed by 4 washes in PBS 
with 1% BSA. Next 1-2 drops of the secondary peroxidase-labeled antibody (diluted 1/1,000 in 
PBS with 1% BSA) was added for all experimental slides but omitted for controls (no primary 
antibody) which were only washed with 1% BSA. Slides were incubated for 1hr at RT then 
washed 5X over 50 min in PBS. Slides were dried and then 1/10 diluted 3'-Diaminobenzidine 
(DAB) metal concentrate (Pierce) in stable Peroxidase Substrate Buffer (Pierce) was added, with 
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the reaction allowed to occur for 10-15min, followed by a distilled water wash.  The slides were 
dehydrated in 80%, 90% and 2x 100% ethanol for 1 min each, then immerse in 2 changes of 
xylene for 1 min each, and mounted with cover slips using Permount. 
 
Fiber Diameter Measurement 
SEM images of pore morphologies, fiber alignments, and fibers size of dry electrospun 
sheets were captured using a Zeiss Evo50 scanning electron microscope. ImageJ 64 (NIH 
shareware) was used to measure fiber diameter. A total of 50 separate fibers in total were used to 
determine the mean fiber size and to calculate the standard deviation from n=3 scaffolds per 
count, with calibration for each image made from the corresponding size scale bar on each SEM 
micrograph. The mean fiber diameter and error was determined using the Student’s t-test. 
.  
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RESULTS: 
After significant testing and protocol modifications, it was determined that the crucial 
step in At-ECM extraction was to freeze-thaw the lipoaspirate using liquid nitrogen prior to 
chemical purification. Lipoaspirate was frozen in liquid nitrogen with subsequent pulverization 
of the frozen sample with a heavy blunt object or in a blender, followed by additional freeze-
thaw cycles in liquid nitrogen or at -80C in order to lyse the resilient adipocytes, which must be 
removed for successful At-ECM harvesting. While only providing around 6.4% yield based on 
estimated dry weights (n=3), the At-ECM extracted using cryotreatment was amenable to 
electrospinning, producing nanofiber scaffolds (Figure 6A and 6B) with a fibrous structure 
similar to electrospun Matrigel (Figure 6C).  
The ability of the purified At-ECM to co-electrospin was also verified with a synthetic 
polymer, PDO, as shown (Figure 6D). The average fiber diameter of the electrospun adipose 
tissue ECM with 80mg/ml and 100mg/ml starting concentration and the fiber size of the 
100mg/ml adipose ECM:PDO blend were also calculated (Table 6). At-ECM concentrated 
above 100mg/ml generally sputtered ECM material onto the collector, and less than an 80mg/ml 
concentration of At-ECM:HFP electrospun erratically and produced extremely thin fibers, 
prohibiting the calculation of any fiber properties. In purifying freeze-thawed At-ECM, we 
observed a well-dissolved mixture of connective tissue when mixed in acetic acid (Figure 6E). 
After dialysis and mild lyophilization, we consistently found a light, fluffy material produced 
with a slight yellow hue (Figure 6F).  
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Figure 6. Adipose ECM Extraction and Electrospinning. At-ECM was electrospun at 
80mg/ml (A) and 100mg/ml (B) produce a biomimetic tissue engineering substrate with fibers 
formed in the biologic ~20-400nm range (A-B), morphologically resembling a related 
electrospun basement membrane matrix of Matrigel (C). At-ECM also readily copolymerized 
when electrospun as blended at 10% At-ECM with 90% PDO (weight per volume) to form a 
nanofibrous mesh (D). The appearance of the freeze-thawed lipoaspirate processed for 24 hours 
in acetic acid is shown while vigorously stirring for reference, free of large floating clumps of 
adipose tissue typical of tissue that was not pre-treated to remove contaminating adipocytes and 
lipids (E). 0.5g of purified, dialyzed and mildly lyophilized At-ECM with a light and fluffy 
texture is shown for reference in a 10cm weighing dish (F). 
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Table 6: Average Fiber Sizes of Pure and PDO Blended Electrospun Adipose ECM 
 Average Fiber 
Diameter 
(n=50) 
Min-Max 
Fiber Size Range 
(n=50) 
80mg/ml Adipose Tissue ECM 130 ±  123 nm 18 – 430 nm 
100 mg/ml Adipose Tissue ECM 298 ±  266 nm 31 – 772 nm 
10:90 Blend of  
100 mg/ml Adipose ECM:PDO 251 ±  56 nm 66 – 348 nm 
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We also determined that briefly lyophilizing the matrix was crucial for successfully 
dissolving the adipose tissue in HFP. To ensure a rapid lyophilization process, the At-ECM was 
frozen in an ice cube tray then blended into small ice chips in a food processor with the chips 
adhering to the walls of the lyophilization containers, which enhances the available surface area 
for a rapid lyophilization process. Excessive lyophilization produced an excessively hard 
material that was resistant to HFP or TFA and thus not amenable to the electrospinning process. 
We also found that a thorough dialysis was required for producing pure ECM for 
electrospinning. By skipping the dialysis step and just collecting digested At-ECM by 
centrifugation with PBS washing and direct lyophylization, this unpurified At-ECM was soluble 
in organic solvent (HFP or TFA) and electrospun, yet the resulting spun matrix appears impure 
and disorganized under SEM (Figure 7A-C), with large particulate matter intertwined within the 
nanofiberous mesh (n=3). 
We observed that standard salt/acid-based ECM purification methods alone fail to 
significantly dissolve At-ECM tissue, leaving adipocyte-dense spheres that persisted even after 2 
weeks of acid digestion and making fat ECM purification yields extremely poor (0.9% yield of 
calculated starting dry tissue weight, or 3% yield with a 1:10 pepsin blend added, n=2). We have 
found that acetone can be used to efficiently lyse the adipocytes in the lipoaspirate, followed by 
isopropanol to wash the acetone, lipids, and cell debris out of the tissue. In two separate trials, 
the acetone/2-propanol processing produced a yellowish and fluffy matrix material (Figure 7D) 
with good yields (~11% starting dry tissue weight). The acetone/2-propanol treatment appeared 
to leave the resulting, partially purified scaffold largely insoluble in organic solvent (Figure 7E), 
and hence unable to be efficiently electrospun. In characterizing this newly derived matrix, the 
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Figure 7. Partially Purified Adipose ECM Extraction and Electrospinning. Adipose matrix 
not dialyzed was electrospun at 60mg/ml to produce a particulate filled fibrous mesh as seen at 
1000x (A), 4000x (B) and 8000x (C). Partially purified, un-dialyzed At-ECM, with its dense and 
strong yellow hue is shown for reference in a 10cm dish (D). Also shown are two batches of 
adipose ECM dissolved in HFP overnight, with one batch (F, left vial) of a freeze-thaw pre-
treated tissue dissolving thoroughly in organic solvent, and the other batch (F, right vial) of 
acetone-isopropanol pre-treated lipoaspirate only partially dissolving in the organic solvent, 
leaving very large clumps of material behind. 
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At-ECM that has been salt extracted showed appropriately sized bands and patterning, similar to 
batches of purified bovine collagen type I (Figure 8), suggesting the presence of type I collagen 
in the mixture.  
 Using histochemical analysis, we further determined the composition of our extracted 
adipose tissue ECM in its native, purified, electrospun, and co-electrospun forms. Our results 
strongly indicate the presence of basement membrane (Jones Stain, Figure 9), collagen (Mason’s 
Trichrome stain, Figure 10), elastic fibers or elastin (Verhoeff-von Gieson stain, Figure 11), and 
connective tissue and collagens (Gomori’s Trichrome Stain, Figure 12) in unprocessed and At-
ECM, all of which were also present after electrospinning At-ECM, and to a lesser degree in a 
electrospun 10:90 At-ECM:PDO blend, as expected. Periodic acid-schiff (PAS, Figure 13) stains 
further suggested an abundance of glycogen, glycoprotein, and proteoglycans in adipose tissue, 
purified fat, and electrospun At-ECM, although PAS only moderately stained At-ECM:PDO 
scaffolds. Finally, immunohistochemistry confirmed the presence of collagen type IV in fat 
tissue, purified At-ECM, and in electrospun At-ECM (Figures 14 and 15). 
In order to better replicate the native cell niche using electrospun At-ECM instead of 
tissue culture plastic, we were able to produce an efficient and effective method for directly 
electrospinning natural and synthetic materials onto tissue culture plastic, illustrated in Figure 16 
A and B. We were able to directly generate electrospun nanofiber-coated culture dishes as 
shown (Figure 16C). Light microscopy analysis confirmed the formation of non-woven fibers 
deposited by electrospinning on the culture dish using At-ECM or PDO (Figures 16D-F) for the 
coating substrate. 
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Figure 8. Adipose Tissue ECM Matrix Composition. At-ECM was extracted from human 
lipoaspirate and bovine skin with selective salt precipitation to isolate type I collagen, with purity 
assayed via SDS-PAGE gel and stained with biosafe Coomassie Blue. In 2 separate extractions 
of calf corium (positive control), were observed two prominent bands at 130 and 260KD, typical 
of type I collagen (lanes 1 & 2). The purified human At-ECM that was salt/acid extracted for 
type I collagen produced a similar banding pattern (lane 4) as purified and suggests that type I 
collagen is present in the purified At-ECM. Additional proteins were apparent in the crude, non-
salt/acid extracted At-ECM (lane 5). 
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Figure 9. Jones Staining for Basement Membrane. Jones stains indicated an abundance of 
basement membrane present in the placenta positive control, fat tissue, purified At-ECM and 
electrospun At-ECM as seen by the red fiber coloration, while lightly staining the electrospun 
At-ECM:PDO scaffold, suggesting the trace presence of basement membrane persisting in this 
blended electrospun processed scaffold (20x). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 64 
 
 
 
Figure 10. Mason’s Trichrome Staining for Collagen. Mason’s Trichrome strongly stained the 
placenta positive control, fat tissue, purified At-ECM and electrospun At-ECM blue, and also 
moderately stained the electrospun At-ECM:PDO scaffold, suggesting the presence of collagen 
in each sample (20x). 
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Figure 11. Verhoeff-Von Gieson (VVG) Staining for Elastic Fibers/Elastin. VVG evenly 
stained the placenta positive control, fat tissue, purified At-ECM and electrospun At-ECM a 
magenta hue, with dense staining localized to the vasculature in the abdominoplasty fat tissue 
sample. VVG also moderately stained electrospun At-ECM:PDO, suggesting the presence of 
elastic fibers or elastin in all sample (20x). 
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Figure 12. Gomori’s Trichrome Staining for Connective Tissue/Collagens. Gomori’s 
Trichrome evenly, strongly and positively stained the kidney positive control, fat tissue, purified 
At-ECM and electrospun At-ECM a light blue coloration, and also moderately stained 
electrospun At-ECM:PDO, suggesting the presence of connective tissue in each sample (20x). 
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Figure 13. Periodic Acid-Schiff Staining for Glycogen, Glycoproteins and Proteoglycans.  
PAS staining indicated that in vivo and purified adipose tissue, as well as electrospun At-ECM 
contained a very large and orderly array of glycogen, glycoprotein, and proteoglycans, indicated 
by the reddish-pink coloration. Such high amount of staining was expected as glycoproteins and 
proteoglycans are covalently cross-linked to collagens in vivo and should remain tightly bound 
through the processing. Normal kidney served as a positive control (40x). An electrospun At-
ECM:PDO blend showed trace PAS staining. 
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Figure 14. Collagen Type IV Protein in At-ECM.  An antibody against type IV collagen was 
used to identify the protein in adipose tissue, purified At-ECM, electrospun At-ECM and At-
ECM:PDO blend, as detected by DAB. The presence of collagen IV is indicated by the brown 
DAB staining against the blue hematoxylin counterstain and compared to placental tissue as a 
positive control (40X).  
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Figure 15. Antibody Control for Collagen Type IV in Adipose Tissue ECM. For validating 
antibody specificity, the antibody against type IV collagen was applied, per figure 9, but without 
the primary antibody, on fat tissue, purified At-ECM, electrospun At-ECM and At-ECM:PDO 
blend, with subsequent application of DAB. DAB was found absent on all experimental (no 
primary antibody) samples and present only on the positive placenta control to which the 
secondary antibody was applied. Images were captured by phase microscopy at 40X. 
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Figure 16. Direct Culture Dish Coating by Electrospinning. A cartoon representation shows 
the typical electrospinning apparatus modified to directly coat fibers by free hanging the dish 
backed with a metal mesh connected to the power supply cathode to attract the spinning fibers 
(A). The modified mesh and 100mm2 dish used is also shown with attached 16ga wire (B), along 
with the appearance of a dish heavily coated with PDO fibers (C). A 40x magnification of coated 
dishes with adipose tissue ECM at 80mg/ml (D) and at 100mg/ml (E) and PDO (F) are shown to 
produce small, randomly arranged fibers of varying density and thickness as visualized by light 
microscopy. 
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Electrospun At-ECM proved stable in warm media, both genipin cross-linked and 
uncross-linked, so uncross-linked scaffolds were used for cell-based experiments. We next 
confirmed the ability of At-ECM matrix to support stem cells. Approximately 25,000 ASCs were 
seeded on At-ECM and a 10:90 At-ECM:PDO blend at day 0, and collected at 1 day and 14 
days. The scaffolds were fixed and processed for H&E staining, which showed the presence of 
cells attached to the electrospun adipose ECM scaffolds at day 1 and 14 for the electrospun discs 
(Fig. 17). After 7 days of culture, around 5% of the cells on the At-ECM-coated material 
accumulated many small lipid vacuoles, highly suggestive of adipogenesis induction just by 
being in contact with the fibers alone, in normal growth media. However, by day 14 these 
vacuoles were undetectable. We further confirmed the presence of cells growing on At-ECM and 
At-ECM:PDO using DAPI, a DNA intercalating agent, to identify cell nuclei. Using ECM 
samples from a different batch of electrospun At-ECM (Fig. 18), DAPI positively indicated the 
presence of ASC growing on the electrospun scaffolds, with a slight increase in cell number 
noted from 1 day to 14 days of culture on electrospun At-ECM fibers (Fig. 18 and Table 6). 
 
   
 72 
 
    
 
Figure 17. Electrospun At-ECM and At-ECM:PDO Blend Supports ASC Viability. ASCs 
were seeded for 1 or 14 days on 10mm punched discs of electrospun pure adipose or a 10:90 
blend of adipose ECM:PDO then fixed for H&E staining as shown (Arrows indicate cells/stained 
nuclei and cytoplasm).  ASCs were also maintained on At-ECM coated dishes and cultured for 
14 days and imaged under DIC microscopy, with At-ECM;PDO scaffolds showing moderate 
cellularity and a highly fractured scaffold fibers. At-ECM coated dishes were highly cellularized, 
yet few of the original electrospun fibers remained visible with phase microscopy (parallel lines 
are a dish artifact from acid-etching). 
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Figure 18. DAPI of ASCs Grow on Electrospun At-ECM and At-ECM:PDO. Around 25,000 
cells/cm2 ASCs were seeded and cultured for 1 to 14 days on 12mm punched discs of 
electrospun pure At- ECM and a 10:90 blend of At-ECM:PDO. The scaffolds were then stained 
with DAPI and imaged on a fluorescent microscope to verify cell attachment to the electrospun 
At-ECM matrices. 
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Table 7: Cell Seeding and Growth of ASCs on Electrospun At-ECM.  
 AVG # CELLS 
DAY 1 
AVG # CELLS 
DAY 14 
Adipose ECM:PDO 3 ±  2 7 ±  3 
Adipose ECM 25 ±  14 53 ±  18 
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DISCUSSION: 
 To our knowledge, this is the first report of the electrospinning of adipose extracellular 
matrix (At-ECM), producing a nanofibrous tissue engineering matrix composed of various 
collagens, basement membrane, and elastic matrix materials, potentially providing a scaffold 
suitable for stem cell cultivation and additional practical applications. While the use of At-ECM 
has just recently garnered attention as an excellent material for tissue engineering (Choi et al., 
2009a; Choi et al., 2009b), previous methods for extracting and processing At-ECM produced 
very large macro-scale fibers and large sheet-like structures, which is atypical of native ECM 
components. In contrast, electrospun At-ECM fibers uniquely mimic the in vivo fibers. Along 
with fibrinogen, At-ECM may be the most abundant and readily accessible patient-derivable 
scaffolding for regenerative medicine and stem cell tissue culture applications. Other than 
harvesting of cadaverous tissue, skin- and At-ECM are among the rare sources of human ECM 
that could potentially be widely collected and banked for medicinal and research purposes. 
Further, plastic surgery clinics have no shortage of liposuction refuse for source materials. 
 Extracting purified At-ECM in suitable quantities for regenerative medicine and tissue 
engineering purposes has proven extremely challenging. The ECM literature, even classical 
ECM papers from the 1940’s-1970’s, sets no precedent (Haaralson et al, 1995). In fact, most all 
ECM extraction protocols from varied tissue sources have within their initial steps a careful 
removal of all fat from the target tissue for discard. The reason for this is that adipose tissue is 
notoriously resilient to chemical treatment, and adipocytes and At-ECM interfere with the 
standard collagen isolations steps. We report here that a rapid freeze-thaw cycling of the adipose 
tissue greatly aids in removing lipids from the dense connective tissue. This allows for 
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purification of the At-ECM without use of expensive chemicals and enzymes, such as pepsin and 
dispase (Choi et al., 2009a), which may damage the ECM and make it undesirable for further 
use. 
 While pre-treating the lipoaspirate or abdominoplasty sections with acetone proved more 
effective in removing adipocytes and lipids from the tissue than our freeze-thawing protocol, the 
resulting acetone-purified tissues unfortunately were unable to dissolve in HFP or TFA organic 
solvents. Given the constant reports of new solvents for electrospinning, it is possible that a 
unique solvent would allow the acetone-treated material to dissolve and electrospin, which 
would lead to a dramatic increase in material yield and simplified purification process. Given our 
extensive research experience with type I collagen and its strict requirement for a rapid 
lyophilization to produce workable purified material, it may also be possible that adjusting the 
lyophilization time of the acetone-treated ECM could alleviate its resistance to common organic 
solvents, which is worthy of further exploration. Alternatively, the acetone/isopropanol treatment 
may be acting in some unknown way to crosslink the connective tissue, thus keeping it from 
becoming soluble. The application of chemical or physical processing to break the cross-links 
may result in a material capable of dissolving in solvents appropriate for electrospinning.  
 We additionally discovered that the At-ECM co-electrospins with PDO, creating biologic 
electrospun fibers in the 250nm diameter range. The ability to blend At-ECM with a synthetic 
polymer reduces the amount of starting At-ECM needed for fabricating a sizeable construct, 
while still potentially having a scaffold with biologically relevant cell binding sites from the At-
ECM. The blended scaffolds also have the advantage of added material strength and elastic 
properties being more actively tailored for the desired tissue type. It is worth noting that while 
   
 77 
the histological stains for collagens, basement membrane, and elastin matrix components were 
positive for the At-ECM:PDO blend, the stains were light and highly scattered throughout the 
sectioned electrospun sheet. Such minimal amounts of material, however, may or may not 
ultimately be sufficient for cell growth, proliferation, migration, and cell-ECM functional 
activity. We are currently investigating various cell types and different PDO blend ratios with 
our electrospun At-ECM material. 
Our protein and extensive histological analyses have given strong indications that the 
ECM types present in adipose tissue in situ, particularly collagen I and IV, basement membrane 
components, and elastic fibers are readily purified by our technique. Moreover we have 
demonstrated that these materials persist in an electrospun state. Given our findings, we believe 
electrospun At-ECM is a promising alternative for Matrigel (Table 7) in some situations. Being 
autologous in nature, the possible uses for research and clinical applications for At-ECM seems 
extensive, particularly when used in concert with autologously derived ASCs, cells already 
proven to have exceptional utility in regenerative medicine (Katz et al., 2006). Potential 
applications for electrospun At-ECM include the culture of embryonic and induced pluripotent 
stem cells, the culture of hepatic cells and stimulating ductal outgrowth of certain breast cells 
prone to branching morphogenesis in Matrigel, to name but a few. The in vivo potential of this 
novel electrospun scaffold material is still unknown, and it remains to be seen whether 
electrospun At-ECM will elicit an immune response if used autogeneically in animal models. 
 Finally, we have discovered a novel method for directly coating tissue culture plastic of a 
culture dish with electrospun fibers, with acid etching and deionizing of the plate coupled to a 
fine steel mesh to provide the cathode for targeting the electrospinning fibers to the plate. This  
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Table 8: At-ECM Fiber Characterization and Material Comparisons Summary  
 
                               Purified &  
              Capillaries and      Electrospun      
ECM proteins  Adipose Tissue1        Small arteries1    Matrigel2    Adipose ECM 
Type I Collagen  +        +         low              + 
Type II Collagen             low        -           -              nt 
Type III Collagen  +      low           -               S 
Type IV Collagen  +      low           +   + 
Type V Collagen  +      low           -               S 
Type VI Collagen  +       +           -               S 
Elastin    +       +           -               + 
Fibronectin   +       +           -              nt 
Laminin   +       +           +               S 
Nidogen               +       +           +              nt 
Proteoglycans,                                     
  Glycosoaminoglycans 
  & Glycoprotein  +       +            +   + 
Adapted from Nakajima et al. 1998 (1) and BD Bioscience product sheet data (2). 
(+)= Positive, (nt) = not tested, (S) = Suggested 
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produced a layer of random fibers on the scaffold that could be layered as a thin coating only a 
few fiber layers thick to a dense layer entirely opaque by light microscopy and measuring more 
than 0.2 microns thick, depending upon the amount of material deposited. This process proved 
useful for supporting the growth of mesenchymal stem cell cultures and may have many other 
applications, such as for use in migration assays, culturing feeder layers, or ECM-dependent cell 
types such as embryonic stem cells and hepatic cells. The prospect of large scale manufacturing 
of dishes or multi-well plates coated with electrospun nanofibers would further hold significant 
potential in medicine and research by replacing non-biologically relevant gel-coated plates as 
standard culture protocol for many cell types. 
 In summary, this study describes a novel tissue engineering scaffold of human adipose 
tissue origin. By electrospinning At-ECM, we are able to create a highly porous 3D scaffold of 
nanofibers with a high degree of interconnectivity. This engineered scaffold retains abundant 
amounts of collagen type I and basement membrane components (collagen type IV, elastin 
fibers, and glycosaminoglycan-based ECM) and supports the adhesion of human ASCs, 
appearing to mildly induce adipogenesis after a week of culture. These findings suggest human 
adipose tissue, from living or even cadaveric donors, could provide a readily harvested source of 
basement membrane biomaterials. Further development of this electrospun At-ECM scaffold will 
likely provide new opportunities in tissue engineering and significant therapeutic applications.  
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-CHAPTER 4- 
RESULTS: RECAPITULATING OSTEOBLASTOGENESIS WITH ELECTROSPUN 
NANOFIBERS AND ADIPOSE STEM CELLS 
ABSTRACT 
Addressing a pressing need for generating new bone in the clinic and for research, we explored 
using electrospun fibrinogen (Fg) nanofibers in concert with adipose-derived stem cells (ASC) 
for stimulating osteoblastogenesis in vitro. Electrospun discs of Fg, polydioxanone (PDO), and a 
Fg:PDO blend were seeded with early passage ASCs, BJ fibroblasts, bone marrow mesenchymal 
stem cells (BM-MSCs), or osteosarcoma cells (MG63s) and grown for 7-21 days in osteogenic 
or regular growth media. These constructs were analyzed weekly both histologically and 
molecularly for evidence of osteoblastogenesis. The appearance of regular, porous, mineralized-
appearing structures were found in osteogenic-induced ASC seeded scaffolds but only with those 
scaffolds containing Fg. We observe robust new collagen synthesis and matrix remodeling on all 
Fg and Fg:PDO scaffolds, the levels of which were elevated over time. There was pronounced 
mineralization throughout bone-induced ASC scaffolds while control scaffolds showed no 
mineral deposition despite excellent cellularity. Analysis of alkaline phosphatase and osteocalcin 
gene expression (qPCR) indicated that electrospun Fg supported osteoblastogenesis. To confirm 
our gene expression result, osteogenic-induced ASCs on Fg scaffolds also stained positive for 
osteocalcin protein, a key marker in osteoblastogenesis. Thus, we find that electrospun Fg and 
Fg:PDO are excellent materials for ASC viability, proliferation, and osteogenic differentiation, 
providing a high-quality biomimetic system to further bone model-based research and 
regenerative medicine advances. 
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INTRODUCTION 
In the U.S. alone over 500,000 surgical procedures are performed annually requiring new 
bone tissue or bone analogues, with 2.2 million grafts annually performed worldwide 
(Giannoudis et al., 2005). While autologous and cadaveric bone grafts have proven effective 
clinically, bone tissue is not free from infection or immunological rejections, with extreme 
enduring pain and donor site morbidity associated with autologous grafts (De Long et al., 2007; 
Huffer et al., 2007; Ahlmann et al., 2002; Sasso et al., 1998). Further, donor bodies are rare, 
which has created a considerable black market for stolen cadaveric bone tissue (Powell et al., 
2006). Failures of the bone organ can occur as the result of numerous clinical conditions, 
including cancers (osteosarcomas or as a target tissue of metastatic cancers), infections 
(commonly osteomyelitis), blunt traumas that may result in non-unions, and congenital defects 
(e.g. osteogenesis imperfecta). Many bone diseases will result in moderate to extreme pain and 
also partial or total loss of mobility. New bone tissues are clearly needed, both to model bone-
related diseases in the lab, and for grafts clinically. New tissue engineering strategies for bony 
repair have developed a major research thrust in orthopaedics. Recent compelling scaffold 
biomaterials and stem cell technology advancements have energized regenerative medicine and 
the tissue engineering of bone, making their clinical acceptance imminent (Olvier et al., 2004). 
With its simplicity, relative affordability, and excellent cellular response, electrospinning 
composite nanofibers is rapidly becoming the standard practice in the tissue engineering of bone. 
Electrospinning produces scaffolds highly amenable to cell adhesion, viability, and osteogenic 
differentiation (Li et al., 2006; Wutticharoenmongkol et al., 2007) using an array of template 
scaffold materials. Electrospinning involves the application of a 15-30kV DC electric potential 
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induced in a polymer solution, or melt, which whips the solution onto a metal collection target, 
leaving a dry polymer fiber in the electrostatic field to be collected as a non-woven fibrous mesh. 
Natural matrix materials, such as collagen, laminin, elastin and silk, with or without supporting 
synthetic blends (polydioxanone (PDO), PLGA, PCL, etc.), can be electrospun into scaffolds of 
nearly any size, shape, or microscopic properties (Venugopal et al., 2008; Barnes et al., 2007; 
Matthews et al., 2002; Bhattarai et al., 2005). Electrospun scaffolds can highly resemble native 
extracellular matrices in geometry, fiber size, and material composition, whereas conventional 
polymer processing techniques generally produce greater than 10µm diameter fibers. 
Our chosen scaffold building material, fibrin(ogen) (Fg), is an integrin-spanning 
glycoprotein that binds collagen, fibrin, and heparan sulfate and has been clinically used for a 
variety of applications for more than 60 years (Giannini et al., 2004). Fg actively binds fibroblast 
growth factor-2 (bFGF), a crucial stem cell signaling molecule, and vascular endothelial growth 
factor (VEGF) (conveniently secreted by ASCs), both factors potentiate endothelial cell 
proliferation and may contribute to the healing response. Fg has another important advantage, 
being an autologous matrix that can be easily purified in as little as 20 minutes (Valbonesi et al., 
2006). Our lab has further demonstrated that fibrinogen can be electrospun with great success 
(McManus et. al., 2006; 2007). As Fg is the primordial wound-healing matrix initially deposited 
in fractured bone, vast potential exists for engineering new bone with this biomimicry blueprint. 
As an alternative to pure Fg matrices, we propose the blending of PDO, a synthetic material 
commonly used in resorbable sutures (Boland et al., 2008) in order to reduce the amount of 
natural matrix required and improve mechanical properties and stability in culture as previously 
reported (Smit et al., 2005).  
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Cells as varied as amniotic and bone marrow-derived mesenchymal stem cells (BM-
MSCs) have been used as a template for developing or repairing bone in recent electrospinning-
based research (Steigman et al., 2009; Thibault et al., 2009). However these progenitor cell types 
are not without complications in their painful extraction, scarcity and often heterologous natures. 
While BM-MSC have been the most widely studied of the mesenchymal stem cell (MSC) types, 
the existence of an analogous adipose-derived stem cells (ASCs) in human fat have gained 
considerable interest (Zuk et al., 2002), in part due to sharing a nearly identical transcriptome, 
immunophenotype, and differentiation potential with BM-MSCs. 
ASCs appear more advantageous than BMSCs, being up to 1,400 times more abundant 
and a more readily accessible tissue source relative to bone marrow (Izadpanah et al., 2006; Kern 
et al., 2006). Liposuction also offers greatly reduced patient morbidity relative to tapping into the 
bone marrow for BMSC extraction. ASCs furthermore are reported to secrete potent growth 
factors in high quantities, such bFGF, insulin like growth factor 1 (IGF-1), hepatocyte growth 
factor (HGF), and VEGF (Wang et al., 2006). These factors are crucial for tissue development 
and regeneration and are likely to prove essential for constructing many artificial tissues. 
Collectively, these advantages make ASCs an ideal stem cell for our studies. 
In light of the increasing need for generating new bone, the primary purpose of this study 
is to determine the osteogenic potential of electrospun fibrinogen scaffolds seeded with ASCs. 
We hypothesize that electrospun fibers of fibrinogen and fibrinogen:PDO are able to support 
ASC attachment, proliferation and osteoblastogenic differentiation, providing the groundwork to 
using entirely autologous materials for various bone-related therapeutics.  
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MATERIALS AND METHODS 
 
Adipose Stem Cell Primary Isolation and Culture 
Lipoaspirate was obtained as surgical waste from patients undergoing elective surgery 
using standard techniques, in accordance with Virginia Commonwealth University’s IRB. ASCs 
were isolated and characterized as described previously (Zuk et. al., 2002, Francis et al., 2010). 
ASCs were cultured in low glucose DMEM (Gibco) with 10% FBS (Hyclone), 10nM 
recombinant human EGF (Sigma), and 1% antibiotic-antimycotic (ABAM, Gibco), and 
incubated at 37°C with 5% CO2. Cells were characterized as multipotent and were shown to 
exhibit a mesenchymal stem cell immunophenotype as we reported previously (Francis et al., 
2010). To determine the immunophenotype of our ASCs, ~100,000 cells were flow sorted on a 
Beckman CoulterEpics XL-MCL for the presence or absence of CD14, CD29, CD31, CD34, 
CD45, CD73, and CD105 and compared to BMSCs. 
 
BM-MSC, BJ and MG63 Cell Culture 
Human foreskin fibroblasts (BJ) were obtained from ATCC (Manassas, VA) and 
expanded in D9C media (DMEM, 1X Medium 199, 10% CCS (Cosmic Calf Serum, Hyclone) 
and 1% ABAM. Cells were incubated at 37˚C and 5% CO2 at 100% humidity. MG63 
osteosarcoma cells were cultured in basic ASC growth and differentiation medias and incubation 
conditions. BMSCs were obtained from the iliac crest of healthy human patient donors in 
accordance with the IRB, using standard isolation procedures (Friedenstein et al., 1976). BMSCs 
were maintained in DMEM supplemented with 10% FBS, 15ng/mL bFGF, and 1% ABAM. 
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Osteogenic Differentiation 
Osteoblastogenesis was induced by cultivating stem cells for 2-4 weeks in osteogenic media 
(OM) as previously described (Zuk et al., 2002), and compared to BMSCs and BJs as positive 
and negative controls, respectively. OM was made of high glucose DMEM with 10% FBS was 
supplemented with 2-ascorbate-2-phosphate, ß-glycerophosphate, and dexamethasone (Sigma-
Aldrich). The control media (CM) was formulated as OM minus dexamethasone.  
 
Adipogenic Differentiation 
ASCs, BM-MSCs, and BJ cells were grown to around 80% confluence in normal ASC 
media, followed by the addition of adipogenic induction media (0.5mM isobutyl-methylxanthine, 
1µM dexamethasone, 10µM insulin, 200 µM indomethacin, and 1% ABAM). Freshly prepared 
adipogenic induction media was changed every 2 days for 14-21 days. The respective cell lines 
were maintained in basic ASC media at confluency as negative controls. Differentiation-induced 
and control cultures were then fixed in 4% paraformaldehyde for 30min, followed by staining 
with Oil Red O for 40min at RT for detection of lipid droplets.  
 
Chondrogenic Differentiation 
Cells were harvested when around 75% confluency, during mid-log phase growth, and 
concentrated at 400 cells/µl in chondrogenic media. Around 250,000 cells in 500µl of media 
were centrifuged for 10min at 450 x g in a 15ml conical tube. The tube was then placed in the 
incubator, humidified at 37ºC with 5% CO2, with a loose cap and allowed to incubate overnight. 
The visible pellet was then transferred to a 12-well plate the next day, with the chondrogenic 
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media changed every 3-4 days for 4 weeks for each pellet. The chondrogenic media consisted of 
high glucose DMEM base, 10ng/ml TGF-ß3 (R&D systems), 1x10-7M dexamethasone (Sigma), 
50µg/ml L-ascorbic-2-phosphate (Sigma), 10µl ITS+/1ml media (B&D Biosciences), 10% FBS, 
1% ABAM. At 21-28 days, the pellet was fixed in 4% neutral buffered formalin (NBF). 
Successful chondrogenesis was verified by Safranin O histochemical staining. Briefly, pellets 
fixed in NBF were first washed in PBS, followed by a brief wash with 1% glacial acetic acid. 
The monolayer culture was then stained with 0.5% Safranin O for 5min until a pink/orange stain 
was observed, then washed, and stored in tap water. As with most cartilage histological stains, 
Safranin O stains proteoglycans and glycosaminoglycans. 
 
Electrospinning Fibrinogen, Polydioxanone and Fibrinogen:PDO 
Solutions of lyophilized bovine fibrinogen (Fraction 1, Type 1-S from bovine plasma, 
Sigma Aldrich) were made with a 10% (by volume) minimal essential medium (MEM, Sigma 
Aldrich) and 90% weight/volume 1,1,1,3,3,3 hexafluoro-2-propanol solution (HFP, TCI 
America, Portland, OR) at concentrations of 100mg/ml. Polymers were allowed to enter solution 
overnight with shaking at RT. Solutions of polydioxanone (PDO) (Ethicon, Somerville, NJ) were 
made at 100mg/ml concentrations, dissolved in HFP overnight with shaking at RT. 
Fibrinogen:PDO blended scaffolds were combined in one vial after mixing overnight with an 
additional 10% MEM to allow the polymers to remain in solution and effectively electrospin. 
A syringe pump (KD Scientific), high voltage power supply (Spellman CZE1000R, 
Spellman High Voltage Electronics Corp.), 1-to-10ml plastic syringes (BD Bioscience) with a 
18.5-gauge blunt-end needle, and a 303 stainless steel mandrel (10.2 cm length x 2.5 cm width x 
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0.3 cm thick) were used for a collection target. Electrospinning parameters were typically 
constant at 30kV applied voltage, 125mm distance between the needle and grounded mandrel, 
2.5mL/hr solution dispensing rate, 2cm/s translational speed over 7cm, and approximately 500 
RPM rotational speed.  
 
Static Scaffold Seeding and Tissue Culture 
Scaffold discs 12mm in diameter were formed with tissue biopsy punches from  
electrospun fibrinogen, PDO and Fg:PDO sheets, with the punches tightly placed in 48-well 
plate. Scaffolds were disinfected in 80% ethanol for 30min, then washed 3 times for 10min in 
PBS. Cells were concentrated to 50,000 cells/100µl, and a single 100µl drop of cells was careful 
placed on the center of the disc. Cells were allowed to adhere in the incubator for 15min and then 
500µl of control or differentiation media was added. Media was carefully changed every 2-4 
days.  
 
Quantitative Real Time RT-PCR 
Total cellular RNA was extracted from electrospun tissues-analogues using Trizol 
Reagent (Gibco) according to the manufacturer’s protocol. For good RNA yield, a set of 5 cell-
seed scaffolds (12mm) were homogenized for each sample condition, being pulverized together 
with a tissue grinder in 1ml of Trizol. RNA concentrations and purity were estimated on a 
Nanodrop spectrophotometer (Thermo Scientific, DE). RNA was reverse transcribed using a 
random hexamer and the SuperScript First Strand Synthesis System (Gibco). A Stratagene 
Mx300P QPCR System (Stratagene, La Jolla, CA) was used for gene expression analysis in the 
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VCU Nucleic Acid Research Facilities core. Taqman primers for 18S, osteocalcin and alkaline 
phosphatase were used. Relative expression levels for the lineage specific genes were calculated 
using standard curves generated from the triplicate dilution series of the cDNA, with 
normalization to the 18S housekeeping gene. Comparative statistical analysis was performed 
using a one-way ANOVA followed by a Tukey test, with the α level set at 0.05. 
 
Histology 
Scaffolds were fixed in 10% formalin, paraffin embedded, cryosectioned and mounted 
for hematoxylin and eosin (H&E), Ki67, and Masons Trichrome staining using a Dako Artisan 
Staining System X automated system at the VCU Anatomical Pathology Research Laboratory. 
For Alizarin Red S (ARS) staining, discs were fixed in ice cold ethanol, then paraffin embedded, 
sectioned then rehydrated for staining. The transverse scaffold sections were incubated at room 
temperature for 30 min in ARS stain with gentle shaking. The staining solution was removed and 
discs washed 4x with water. The stained constructs were mounted on slides and then visualized 
by phase microscopy.  
 
Microscopy 
For SEM evaluation of the structural morphology of seeded and unseeded electrospun 
scaffolds, constructs were fixed in gluteraldehyde and processed by standard methods with gold 
sputter coating prior to analysis by a Zeiss EVO 50 XVP (Nano Technology System Division, 
Carl Zeiss). For confocal fluorescence microscopy scaffolds were washed with PBS and fixed 
with 3.7% paraformaldehyde for 30min, then permeabilized with 0.5% Triton X-100 for 10min. 
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Following PBS washing, cells were blocked with 4% goat serum in PBS for 1hr, then incubated 
in 4% goat serum in PBS with a polyclonal antibody for osteocalcin (100µg/ml) overnight at 4oC 
in a humidified chamber. After rewashing with PBS, cells were incubated in a 4% goat serum 
solution in PBS with AlexaFluor 488 goat anti-rabbit IgG (Invitrogen A21245) for 1h at RT. 
Cells were stained with 4’,6-diamidino-2-phenylindole (DAPI) upon mounting in Vectashield 
(Vector Lab H-1000). A Leica TCS-SP2 AOBS confocal laser scanning microscope was used to 
capture images, using Leica LCSLite imaging software. Phase and fluorescent microscopy 
images were captured on an Olympus BX51 using Q-Capture Pro software (QImaging). 
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RESULTS 
Using common histological stains, we initially verified that our ASC strains on tissue 
culture plastic were capable of adipogenic differentiation (Oil Red O), chondrogenesis (Safranin 
O), and osteogenesis (Alizarin Red S) (Fig. 19-21). Late-stage osteogenesis was confirmed by 
the expression of osteocalcin secreted by differentiated cells (Fig. 22). Young ASCs (PD4-6) 
analyzed by flow cytometry exhibit an immunophenotype of CD14-, CD29+, CD31-, 
CD34low/+, CD45-, CD73+ and CD105+, which was identical to BM-MSCs for all markers 
except CD34 (absent for CD34) (Fig. 23 and Table 8). BJ fibroblasts and HL60 cells served as 
useful controls, where HL60s were positive for CD14, CD31, and CD45 to confirm antibody 
function. 
With the stem cell attributes of our ASC strains confirmed, their ability to attach and 
remain viable on electrospun sheets of Fg and PDO was assessed using SEM. ASCs seeded on 
Fg scaffolds for 1 day and 7 days showed strong attachment and apparent scaffold surface 
migration and proliferation over time. No cells were detected on pure PDO scaffolds (Fig. 24). 
Unexpectedly, it was found that early passage ASC (<PD 10) exhibited strikingly distinct 
morphology compared to later passage ASCs (>PD 20) as shown (Fig. 24e-f), with the later 
passage ASCs morphologically resembling fibroblasts. Based on these observations, early 
passage ASCs were used for all subsequent experiments.  
To determine the long term viability and proliferative and migratory potential of ASC 
into the scaffold interior for each matrix type, around 50,000 cells were grown on discs and 
collected every 7 days for H&E and Ki67 staining. Since cross-linking Fg leaves the scaffold 
impermeable to ASCs and fibroblasts (Sell et al., 2008), scaffolds were left in their native,  
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Figure 19. Adipogenic Differentiation. ASC cells strains 8 and 9, BM-MSCs and BJs were 
cultured for 2 weeks in adipogenic induction media or regular growth media, fixed and stained 
for hematoxylin and Oil Red O for lipid detection. ASCs and BM-MSCs showed positive 
staining in induction media only, where BJ’s did not indicate any apparent staining (20x). 
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Figure 20. Chondrogenic Differentiation. Two ASC cell strains (#8 and #9), control BM-
MSCs and BJs were cultured for 4 weeks in chondrogenic induction media as micromass cell 
pellets or as unpelleted cells, fixed and stained with Safranin O to detect proteoglycans. 
Unstained and uncut micromass pellets are shown for reference for relative size, morphology and 
texture from each line. ASCs and BM-MSCs showed positive staining in induction media only 
and formed solid, spherical pellets, where BJ’s did not indicate any apparent staining and did not 
form a distinct micromass pellet (10x). 
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Figure 21. Osteogenic Differentiation. ASC cells strains -8 and -9, control BM-MSCs and BJs 
were cultured for 3 weeks in osteogenic induction media or regular growth media (Osteogenic 
media minus Dexamethasone), fixed and stained for hematoxylin and Alizarin Red S for calcium 
deposition. ASCs and BM-MSCs showed positive staining in osteogenic induction media only, 
where BJ’s did not indicate any apparent staining (20x). 
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Figure 22. Osteocalcin Expression in Differentiated ASCs. BJ fibroblasts, ASC8 and ASC9 
cells strains cultured 21 days in osteogenic media on tissue culture plastic were stained for 
osteocalcin (green) and DAPI (blue), and imaged under fluorescence microscopy, as grown in 
coltron media (CM) or osteogenic media (OM). Only the ASC strains showed the expression of 
the secreted osteocalcin protein. ASCs grown in normal growth media and stained with DAPI 
and osteocalcin and ASCs grown in osteogenic media but not stained with the primary antibody 
are shown for negative controls. 
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Figure 23. ASC Immunophenotype. Representative flow cytometry results of our ASC cell 
strains show a typical MSC immunophenotype of CD14-, CD29+, CD31-, CD 45-, CD73+, 
CD105+ and CD34 low/+ (dot plot for CD34 shown for better elucidation of positive sub-
population present).  
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Table 9: Comparisons of ASC, BMSC and BJ Fibroblast Immunophenotypes.  
 CD14 CD29 CD31 CD34 CD45 CD73 CD105 
ASCs - + - +/low - + + 
BM-MSCs - + - - - + + 
BJ 
Fibroblasts - + - - - + + 
HL60 + n.t. + n.t. + n.t. n.t. 
n.t = not tested. 
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Figure 24. SEMs of Electrospun Fibrinogen Supporting Adipose Stem Cells. SEM images of 
ASCs on electrospun fibrinogen at 1 week growth at 500x (A) and at 1000x (B) shows cells with 
extensive cell-cell and cell matrix interactions. A 4000x view of panel “B” of a single ASC 
suggests de novo matrix deposition though visible fibers present that are much smaller (40-80nm 
range) then typically formed by the Fg electrospinning process (~300nm) (C). SEM of a 
confluent sheet of late passage (PD 15+) ASCs covering the matrix at 14 days (D) with a flat 
sheet of non-distinct cells is distinct from young, early passage ASCs upon the fibrinogen matrix 
at 14 days in culture (E) that show a unique blebbing morphology. The irregular and 3D 
morphology of young ASCs on fibrinogen is a feature further suggested by a live/wet mount 
SEM of the construct (F).  
   
 98 
un-crosslinked state after electrospinning. In our initial studies on PDO, few cells attached and 
no cells penetrated the scaffold surface, yet, on pure Fg and Fg:PDO scaffolds, high cellularity at 
14 and 21 days of culture was observed with apparent scaffold penetration (Fig. 25A-D). These 
results were further confirmed though DAPI staining of the nuclei of ASCs that have 
incorporated into the matrix of 50:50 and pure Fg scaffolds grown for 14 days in control media 
(Fig. 25E-F).   
There was an overall significant increase (p<0.05) in cell number in 50:50 Fg:PDO and 
Fg scaffolds as compared to pure PDO scaffolds, comparing ASCs growing in osteogenic or 
growth media to BJs and MG63s as controls, from 7, 14 and/or 21 days (Fig. 26), with 
representative images shown for comparison (Fig. 27-32). Interestingly, we maintained ASCs on 
electrospun fibrinogen for 75 days in culture, with sections of H&E stained scaffolds from 3 
different punches showing cells persisting after 2.5 months of culture (Fig. 33). At day 75, the 
fibrinogen discs still remained solid and associated, macroscopically appearing to have a rougher 
texture relative to day 1 discs.  
By assessing mitotically active cells using Ki67 staining (Fig. 34), we calculated the 
average number of proliferative cells to be highest (p<0.05) in pure Fg containing scaffolds at 
week 1 in osteogenic media (14.8%), decreasing weekly to 11.7% after 2 weeks and 8.0% of 
cells at 3 weeks of differentiation. Cells in growth media at week 3 showed a comparable 
percentage of proliferative cells (8.8%) (Table 9 and Fig. 35). The average percent of 
proliferative cells found on Fg:PDO scaffolds was less than that seen on pure Fg scaffolds at all 
time points. The number of cell layers formed in PDO, Fg:PDO, and pure Fg scaffolds was also 
quantified. A singe-cell layer of ASCs was found to circumscribe the periphery of pure PDO  
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Figure 25. ASC Cellularity and Penetration of Electrospun Scaffolds. ASCs seeded on 50:50 
blended fibrinogen:PDO (A, C, E) and pure fibrinogen (B, D ,F) showed a thick layering of cells 
of the scaffold surface with cells seen throughout the constructs at 2-3 weeks of culture as 
assayed by H&E (a-d) or DAPI staining (e and f). Arrows indicate areas containing one or more 
cells (nuclei) in H&E sections. 
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Figure 26. Electrospun Scaffold Cellularity. The average number of cells (ASCs, BJ’s or 
MG63’s) growing on PDO, Fibrinogen or Fibrinogen:PDO was determined over 1, 2 or 3 weeks 
in culture with osteogenic media (OM) or control/growth media (CM) by averaging the number 
of cells seen in 10 random fields at 40x scored in triplicate. A trend of increasing cellularity with 
increasing Fg content seen with ASCs, while ASCs grown in CM for 3 weeks appeared most 
proliferative in this experiment. BJ fibroblasts were not apparently viable in OM on any 
electrospun scaffold type tested, though were viable in normal ASC CM (osteogenic media 
minus dexamethasone). (Statistical analysis performed by One Way ANOVA with p<0.05. 
*=significant increase in cell number over PDO scaffolds, **=significant increase in cells over 
both PDO and 50:50 scaffolds, as compared at the respective time point). 
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Figure 27. H&E Histology of Osteo-Induced ASCs on Fibrinogen, Fibrinogen:PDO, and 
PDO at Day 7. H&E stained sections of electrospun fibrinogen revealed excellent ASC 
cellularity at 7 days of culture in osteogenic differentiation media with cells found throughout the 
construct. The 50:50 fibrinogen:PDO scaffolds supported a thick layer of cells on the surface, 
and pure PDO scaffolds appeared largely acellular apart from a thin encapsulating cell layer. 
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Figure 28. H&E Histology of Osteo-Induced ASCs on Fibrinogen, Fibrinogen:PDO, and 
PDO at Day 14. H&E stained sections of electrospun fibrinogen reveal excellent ASC cellularity 
maintained at 2 weeks of culture in osteogenic differentiation media with cells found throughout 
the construct. The 50:50 blended fibrinogen:PDO scaffolds maintained a 4-5 layers of cells on 
the surface with some cells seen inside the construct, and pure PDO scaffolds appeared acellular 
apart from a few cells seen on the periphery. 
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Figure 29. H&E Histology of Osteo-Induced ASCs on Fibrinogen, Fibrinogen:PDO, and 
PDO at Day 21. H&E stained sections of electrospun fibrinogen reveal excellent ASC cellularity 
at 21 days of culture in osteogenic differentiation media with cells seen throughout the construct. 
The 50:50 fibrinogen:PDO scaffolds were still seen supporting separate outer layer of cells on 
the surface with many cells found inside, and pure PDO scaffolds appear again acellular in the 
scaffold interior with a few cells found surrounding the construct. 
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Figure 30. H&E Histology of ASCs on Fibrinogen, Fibrinogen:PDO, and PDO at Day 21 in 
Control Media. H&E stained sections of electrospun fibrinogen reveal excellent ASC cellularity 
at 21 days of culture in ASC control media, with cells found throughout the construct. The 50:50 
fibrinogen:PDO scaffolds supported an apparently confluent layer of cells encasing the surface 
of the scaffold, and pure PDO scaffolds appeared scarcely cellular apart from a thin layer of cells 
around the construct. 
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Figure 31. H&E Histology of BJ Fibroblasts on Fibrinogen, Fibrinogen:PDO, and PDO at 
Day 14 in Osteogenic Media. H&E stained sections of BJs on electrospun scaffolds reveal an 
absence of fibroblasts at 14 days of culture in osteogenic differentiation media in fibrinogen, 
50:50 fibrinogen:PDO, and pure PDO scaffolds. 
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Figure 32. H&E Histology of MG63 Osteosarcoma cells on Fibrinogen, Fibrinogen:PDO, 
and PDO at Day 7. H&E stained sections of electrospun fibrinogen revealed high MG63 
cellularity at 7 days of culture. MG63s also penetrated and layered efficiently into 
fibrinogen:PDO scaffolds, while pure PDO scaffolds appeared to support very few cells. 
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Figure 33. Day 75 in Culture on Electrospun Fibrinogen. ASCs grown in culture for 75 days 
on electrospun fibrinogen in control media and stained with H&E, with fields 3 of cellularized 
scaffolds shown for comparison (disc A and A with magnification, disc B & disc C). Ethanol 
cross-linked acellular fibrinogen scaffolds left in media for 75 days and H&E stained and are 
shown for reference as a control. 
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Figure 34. Ki67 Staining of ASCs Proliferation in Electrospun Fibrinogen. In either 
osteogenic (OM) or control media (CM) on pure fibrinogen, ASCs were found to retain a small 
population of mitotically active cells from 7-21 days of culture, as seen through positive Ki67 
staining as the black/brown stained nuclei, which are demarked by arrows in the figures.  
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Table 10: Percentage of Ki67 Positive cells. 
Samples Average # of Cells 
(n=5) 
% Ki67+ 
(n=5) 
Fg:PDO OM D7 244±66 4.5±1.2 
Fg:PDO OM D14 222±83 5.4±1.7 
Fg:PDO OM D21 238±56 1.7±0.8 
Fg:PDO CM D21 235±69 6.0±0.7 
Fibrinogen OM D7 411±103 14.8±2.1 
Fibrinogen OM D14 311±77 11.7±1.4 
Fibrinogen OM D21 224±60 8.0±0.6 
Fibrinogen CM D21 670±141 8.8±3.2 
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Figure 35. Percentage of Ki67 Positive cells.  The average number of Ki67+ cells are shown 
along with the average number of total cells seen in the averaged fields for ASCs grown in either 
osteogenic (Osteo) media or control/growth media (Growth) from 1-3 weeks, on pure fibrinogen 
and on fibrinogen:PDO (Fg:PDO). (Statistical analysis performed by One Way ANOVA with 
p<0.05. *=significant increase in Ki67 cells over PDO scaffolds, **=significant increase in Ki67 
cells over both PDO and 50:50 scaffolds, as compared at the respective time point). 
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Figure 36. Cell Layers Formed with Electrospun Scaffolds.  Electrospun PDO, Fg and 
Fg:PDO scaffolds were observed to form a clearly structured cell layer towards their surface 
when seeded with ASCs, BJs or MG63 cells, with clear difference seen in the thickness of the 
apparent tissue formed. Cells were grown in osteogenic media (OM) or control media (CM) and 
scored on representative fields at 40x.  Cells on PDO formed a uniform single-layer thick barrier 
on the scaffold exterior, while ASCs on Fg:PDO formed an extremely even 4-5 cell layer thick 
barrier, with ASCs of pure fibrinogen creating a thick cell wall from 7-12 cells thick. This is in 
contrast to BJ fibroblast that formed no more then a 1-2 cell layer thick barrier on the periphery 
of the scaffold on all material types. (Statistical analysis performed by One Way ANOVA with 
p<0.05. *=significant increase in cell layers over PDO scaffolds, **=significant increase in cell 
layers over both PDO and 50:50 scaffolds, as compared at the respective time point). 
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scaffolds with no cells penetrating the interior (Fig. 36). The Fg:PDO scaffolds had 4-5 cell layer 
thick envelope around the scaffold with some cells within the scaffold, while pure Fg had many 
cells within the interior  of the scaffold and the thickest number of cell layers formed, averaging 
8-12 (Fig. 36), suggesting ASCs had lost their contact inhibition on electrospun Fg.  
To complete the characterization of ASCs on Fg- and PDO-containing scaffolds, we 
wanted to determine if the ASCs were able to remodel the spun matrix and lay down their own 
native extracellular matrix (ECM). Using Mason’s Trichrome stain, which detects newly 
synthesized collagen, ASCs were able to dramatically remodel their new environment, laying 
down new collagen in place of existing Fg from 1 week to as many as 10 weeks of culture in 
both pure electrospun Fg (Fig. 37) and on electrospun Fg:PDO (Fig. 38). 
To evaluate the potential of ASCs seeded on electrospun Fg to form mature bone-like 
material, we assayed for calcification of Fg, Fg:PDO, and pure PDO scaffolds with bone-induced 
ASCs at 21 days in culture using Alizarin Red S (ARS) staining to detect calcified matrix (Fig. 
39). While pure PDO scaffolds showed a marked absence of staining, matrix mineralization was 
clearly detected under light and fluorescent microscopy for Fg:PDO and particularly with pure 
Fg scaffolds at day 21, with staining appearing to become more intense with time on ASCs 
grown on pure Fg scaffolds (Fig. 40). Fg scaffolds seeded with ASCs in osteogenic media (OM) 
without dexamethasone (control media, CM) for 21 days showed little if any ARS staining at 21 
days of culture (Fig. 40D). 
We further observed that bone-induced samples with Fg and Fg:PDO became hard and 
brittle phenotypically. In order to further define the changes in scaffold surface topology, we 
performed SEM of the bone-induced samples at 21 days. Only the ASC-containing scaffolds (not  
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Figure 37. Mason’s Trichrome of ASCs on Electrospun Fibrinogen. Masons Trichrome stain 
of two ASC cell strains (ASC-8 and ASC-9) grown on electrospun fibrinogen for 1 day (A,E), 1 
wk (B,F), 2 weeks (C,G) and 10 weeks (D,H) along with an acellular control grown in 
osteogenic media for 21 days (J) and a positive trichrome stain of the human kidney (I), 
indicating increasing ASC collagen deposition with time. 
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Figure 38. Mason’s Trichrome of ASCs on Electrospun Fibrinogen:PDO. Masons Trichrome 
stain of ASCs (strains -8 and -9) grown on electrospun fibrinogen:PDO 50:50 blend for 7 (A,D) 
and 21 days (B,E) in culture show vast new collagen deposition seen though 3 weeks of culture 
with ASCs of 2 representative strains, along with an acellular electrospun Fg:PDO (C) and 
positive trichrome of kidney (F) shown as controls . 
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Figure 39. Mineralization of Electrospun Fg, PDO and Fg:PDO at Day 21. Phase 
microscopy images of ASCs grown in osteogenic media upon electrospun PDO (A), Fg:PDO (B) 
and pure fibrinogen (C) scaffolds for 21 days and stained with Alizarin Red S are shown under 
phase and fluorescent microscopy. 
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Figure 40. Mineralization on Electrospun Fibrinogen Time Course. Phase and fluorescent 
microscopy images of ASCs grown in osteogenic media upon electrospun fibrinogen for 7 days 
(A), 14 days (B,E) and 21 days (C,D,F) and stained with Alizarin Red S, along with a control 
scaffold grown in control media for 21 days that lacked apparent mineralization (D). Fluorescent 
images are shown for contrast and to indicate specific staining of the Alizarin Red fluorochrome 
on and between the scaffold fibers. 
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acellular, MG63-, or BJ-seeded scaffolds) exhibited a remarkable change in morphology to the 
structured topology shown (Fig. 41), having features suggestive of scaffold mineralization, 
which is consistent with our previous findings using a chemical mineralization protocol 
(Madurantakam et al., 2009). This is in stark contrast to the fibrous scaffolds found in Figure 24 
with ASCs grown in control/growth media on the same matrix, which essentially left the scaffold 
unchanged.  
To determine if mature bone proteins were being synthesized and incorporated into the 
electrospun Fg matrix, osteocalcin expression of osteo-induced ASCs on electrospun Fg was 
assessed using immunofluorescence and confocal microscopy. No antibody controls showed a 
mild fiber auto-fluorescence in each panel, slightly obscuring the signal (Fig. 42). However, the 
presence of osteocalcin protein is clearly observed in the area surrounding the cells in osteo-
induced scaffolds on pure Fg and Fg/PDO blended scaffolds, with the intense signal absent on 
control media scaffolds (Fig. 42). MG63 cells grown on electrospun Fg and Fg:PDO also 
showed strong osteocalcin expression in the ECM. 
To further assess ASC osteoblastogenesis in electrospun Fg scaffolds, quantitative RT-
PCR was performed revealing relatively higher level of Runx2 expression at 1 week of culture in 
both osteogenic and control media (osteogenic media without dexamethasone) at day 7 relative 
to day 21 for ASCs and BM-MSCs on pure Fg scaffolds (Fig. 43). MG63 cells on electrospun Fg 
showed minimal Runx2 expression, as expected. A significant increase in alkaline phosphatase 
(ALP) gene expression was found at 3 weeks of differentiation as compared to 1 week of 
differentiation and also as compared to ASCs seeded on Fg for 1 and 3 weeks in control media 
(osteogenic media minus dexamethasone) (Fig. 44). BM-MSCs and MG63 controls did not  
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Figure 41. Topography of Bone-Induced ASCs on Electrospun Fibrinogen.  ASCs 
maintained in osteogenic differentiation media are shown at 7-21 days of differentiation (D-F) 
via SEM (5000x) showed a unique, apparent calcified morphology on the surface. BJ fibroblasts 
were also grown in osteogenic media for 21 days on fibrinogen for a negative control (C) and 
these cells lacked the topographical changes seen with ASCs in osteogenic media. ASCs grown 
on PDO at day 14 and beyond showed limited cellularity on the scaffold surface (B), and MG63 
osteosarcoma cells shown at day 7 on fibrinogen for reference appeared unchanged at the 
scaffold level (A). 
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Figure 42. Osteocalcin Expression of Osteo-induced ASCs on Electrospun Fibrinogen. 
ASCs were seeded upon electrospun fibrinogen or fibrinogen:PDO and cultured for 21 days in 
osteogenic media, then labeled with DAPI and immunolabeled for  osteocalcin. ASCs grown on 
spun fibrinogen without osteogenic differentiation were used as a negative control. A no primary 
osteocalcin antibody negative control is also shown for reference on the bottom panel, with very 
faint fiber auto-fluorescence seen at the 488nm detection wavelength. Mild fiber auto-
fluorescence in seen in the each panel, yet osteocalcin expression is seen strongly in samples 
grown in osteogenic media yet nearly absent in growth media. 
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Figure 43.  qRT-PCR Analysis of Runx2 Expression in Osteo-induced Cells on Electrospun 
Fg and Fg:PDO. Quantitative RT-PCR showed a significantly higher level of Runx2 expression 
at 1 week of culture in both osteogenic media (OM) and control media (CM, which is osteogenic 
media without dexamethasone) for ASCs and BM-MSCs grown on fibrinogen scaffolds. This 
effect is lost by the 3 week point in each case. (Analysis by One Way ANOVA followed by a 
Tukey’s test for pairwise comparison, with *p<0.05 and considered significant). 
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Figure 44.  qRT-PCR Analysis of Alkaline Phosphatase (ALP) Expression in Osteo-induced 
Cells on Electrospun Fg and Fg:PDO. Alkaline phosphatase (ALP) gene expression was seen 
to increase markedly in ASCs at 3 weeks of differentiation in osteogenic media (OM), as 
compared to 1 week of differentiation and also as compared to ASCs seeded on fibrinogen for 1 
and 3 weeks in control media (CM, or osteogenic media minus dexamethasone). Fg:PDO 
scaffolds appeared to have a potential osteo-inductive effect on ASCs, with high levels of ALP 
seen at 1 week of culture of ASCs in both CM and OM. BM-MSCs and MG63 cells were not 
shown to express significant levels of ALP on any scaffold type or time point as grown in OM 
(Analysis by One Way ANOVA followed by a Tukey’s test for pairwise comparison, with 
*p<0.05 and considered significant). 
   
 122 
express significant levels of ALP at any time point grown in osteogenic media. In terms of 
osteocalcin gene expression, only ASCs in osteogenic media seeded on pure electrospun Fg 
scaffolds showed significant upregulation of osteocalcin relative to 1 week of differentiation, and 
compared to 1 and 3 weeks of growth in control media on electrospun fibrinogen (Fig. 45). The 
positive control, MG63 cells, showed high osteocalcin expression on Fg, while BM-MSCs 
expressed little osteocalcin at day 7 or 21. 
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Figure 45.  qRT-PCR Analysis of Osteocalcin Expression in Osteo-induced Cells on 
Electrospun Fg and Fg:PDO. ASCs in osteogenic media (OM) and seeded on pure electrospun 
fibrinogen scaffolds showed significant upregulation of osteocalcin expression relative to 1 week 
of differentiation and to 1 and 3 weeks of ASC growth in control media (CM, or OM -Dex) on 
either scaffold type. MG63 cells showed moderate expression on Fg and high expression on 
Fg:PDO (Analysis by One Way ANOVA followed by a Tukey’s test for pairwise comparisons, 
with *p<0.05 and considered significant). 
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DISCUSSION 
We show that electrospun nanofibers of Fg and a 50/50 Fg:PDO blend, but not 
electrospun pure PDO, are viable support materials for adipose-derived mesenchymal stem cell 
proliferation and osteoblastogenic differentiation. Electrospun Fg, in pure form or blended with 
PDO, can support osteoblastogenesis of ASCs in producing an engineered material that is similar 
to bone in its topography, gene expression, phenotype, and protein composition. While many 
approaches for generating artificial bone ex vivo have been developed with varying success, 
using autologous and biomimetic Fg nanofibers seeded with patient-derived ASCs as osteoblast 
precursors is a natural approach, important for basic science research and potentially clinical 
uses. As Fg is the primordial wound-healing matrix initially deposited after a bone fracture, there 
is tremendous potential for developing new bone with a biomimicry blueprint using 
electrospinning with Fg and ASCs.  
Our results show that electrospun Fg and Fg:PDO are fully capable of supporting the 
proliferation of ASCs in vitro. Interestingly, with ASC grown in osteogenic differentiation 
media, we noted a general increase in cell number for up to two weeks of growth in electrospun 
Fg-containing scaffolds with a decrease in the total cell number at the third week, which 
corresponded to a decrease in mitotic activity from the first to third week of culture in osteogenic 
media. Conversely, ASCs grown in basic growth media on electrospun fibrinogen scaffolds 
exhibited a dramatic increase in cell number at the 3-week time points relative to ASCs grown in 
osteogenic media at any point. This data suggests that more ASCs in OM are exiting the cell 
cycle with time, perhaps either becoming quiescent, senescent, or more likely committing to 
differentiate into a mature bone cell type. Despite higher total numbers of ASCs at 3 weeks on 
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electrospun Fg with cells grown in growth vs. differentiation media, Ki67 staining was similarly 
high at 3 weeks for cells grown in both media types, with only around 8% of the cells showing 
mitotic activity.  
Another interesting note on scaffold cellularity was the clear thin layer of ASCs found 
forming around PDO scaffolds. As ASCs contact inhibit in culture on tissue culture plastic, this 
response might be expected of ASCs on electrospun PDO or other materials. However, it 
appeared that ASCs either lost their contact inhibition on electrospun Fg, becoming capable of 
forming very thick 8-15 cell layer thickness across the top of this material. Additionally, ASCs 
were able to migrate into the scaffold in a controlled, layering manner, while still layering atop 
the scaffold. The nature of the H&E histology sections blurred the distinction between cells 
layering on top of the scaffold and penetrating into the scaffold to form layers, yet the 
appearance of large sheets of organized cells reminiscent of actual tissue was striking, and such 
order is rarely observed with other cells type on any electrospun material. 
Synthetic materials are valued in tissue engineering due to their mechanical strength, 
elastic properties, and their general affordability and abundance relative to naturally derived 
materials. Yet synthetic materials tend to have poor cell-matrix interactions and can cause 
undesirable responses to the host immune system. It has been shown that the typically poor 
cellular response for many synthetic polymers can be substantially improved by the addition of 
natural materials (Kim et al., 2007). We show the typical poor cell response and poor 
osteoblastogenic potential of a synthetic material, PDO, can be enhanced by the addition of a 
natural ECM, Fg, with improved cellularity and osteoblastogenic differentiation potential. 
Determining the ideal ratio of Fg:PDO to obtain the maximal amount osteoblastogenesis, thereby 
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increasing mechanical strength and reducing the amount of Fg required therapeutically, is an 
exciting future direction of our work.  
With its simplicity, relative affordability, and excellent cellular response, electrospinning 
composite nanofibers is rapidly becoming the standard practice in the tissue engineering of bone. 
Electrospinning produces scaffolds highly amenable to cell adhesion, viability, and osteogenic 
differentiation (Vepari et al., 2006, Wutticharoenmongkol et al., 2007, Venugopal et al., 2008) 
using an array of template scaffold materials. The electrospinning of Fg nanofibers, first 
published by Wnek et al. (2003), has provided a tissue engineering scaffold with significant 
research and therapeutic potential. The preliminary neonatal rat cardiac fibroblast (McManus et 
al., 2007a) and human bladder smooth muscle cell (SMC) (McManus et al., 2007b) culture 
experiments validated the high bioactivity of electrospun Fg scaffolds, with fibroblasts migrating 
and depositing new collagen, and SMCs placing new collagen almost completely throughout the 
scaffold within 2 weeks. Prior publications with electrospun Fg scaffolds ultimately lacked the 
requisite mechanical integrity to serve as tissue engineering scaffolds without crosslinking, a 
problem shared with electrospun collagen (McManus et al., 2006).  
In contrast to previous studies, we show that ASCs inherently possess a unique ability to 
remodel a sustainable scaffold in extremely long term culture. For up to 75 days of maintenance 
culture, ASCs produced a highly cellularized Fg scaffold composed of new collagen and other 
ECM materials, making this an excellent and highly symbiotic combination of cells and 
materials for regenerative medicine purposes. The mechanical properties of electrospun Fg may 
be augmented by chemical crosslinking (Sell et al., 2008) or by adding synthetic polymers such 
as PDO to the fibrinogen scaffold (McManus et al., 2008) to produce a more stable scaffold in 
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culture. Unfortunately, our results showed that these approaches inhibit the cellular response for 
ASCs. Using a cell type (ASC) capable of rapidly synthesizing its own stable ECM may be the 
ideal approach for minimizing adverse cell-matrix responses and for enhancing cellularity, an 
important feature of a scaffold intended for therapeutic ends. 
qRT-PCR revealed higher level of Runx2 expression at 1 week of culture in both 
osteogenic and control media at day 7 relative to day 21 for ASCs and BM-MSCs on pure Fg 
scaffolds. This unexpected data suggests a number of plausible explanations, including the 
optimal expression window for Runx expression may have been missed or that the matrix itself 
induced a mild osteogenic phenotype. One other the possibility is that the absence of 
dexamethasone only prevents full osteoblastogenesis, and ASCs can begin the differentiation 
process with Runx2 being an early marker only. Alternatively, Runx2 levels may be elevated in 
ASCs and a high baseline may have skewed the results. A finer analysis of Runx2 expression 
over more early time points would be required to better explain these results.   
ASCs have recently been shown to exhibit enhanced proliferation and osteoblast 
induction by seeding the cells on tricalcium phosphate coated electrospun PCL nanofibers 
(McCullen et al., 2009). The ability of a scaffold to maintain and induce differentiation is a 
critical parameter of an ideal scaffold for therapeutic use (Khan et al., 2008). The data presented 
here indicates that the blending of Fg and PDO appears to have an early osteoblastogenic 
inductive effect in our studies, as shown by qRT-PCR results. Determining the full extent of this 
induction with a finer time course following the upregulation of early differentiation marker 
genes is part of our future work. 
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Cells as varied as amniotic mesenchymal stem cells and BM-MSCs have been used as a 
template for developing or repairing bone in very recent electrospinning-based research with 
great results (Steigman et al., 2009, Thibault et al., 2009). These progenitor cell types are not 
without complications however in their painful extraction, scarcity, or heterologous nature. Here, 
we report the novel findings that ASCs, an abundant, autologous, and readily accessible 
progenitor cell, are a practical cell type for modeling osteoblastogenesis in tissue engineering 
with electrospun scaffolds, using a potentially autologous scaffold material, Fg, as well. In 
furthering the autologous cell and scaffold research, future studies using Fg and ASC-derived 
from the same patient would be a natural next step. 
Surprisingly, little work has been done with adipose-derived or other adult stem cells 
seeded within any type of electrospun matrices, leaving much uncharted territory for discovery in 
many systems. Overall, our model presents an attractive template for future clinical and 
regenerative medicine research studies, for repairing bone and other tissues with abundant, 
affordable, and easily accessible and workable materials.  
   
 129 
 
-Chapter 5- 
Discussion and Future Directions 
 
Adipose Stem Cell Characterization and Rapid Isolation 
We have shown in chapters 3 and 4 a thorough characterization of newly derived adipose 
stem cell strains, as well as an improved technique for isolating viable population of 
mesenchymal stem cells from lipoaspirate saline using minimal reagents and a half hour of 
effort. We show these cells to share multipotent differentiation potential and immunophenotype 
with BMSCs.  
In establishing our ASCs as a mesenchymal lineage with properties typical of MSCs, we 
assessed the immunophenotype of ASCs using markers typically associated with the MSC cell 
surface fingerprints as before (Izadpanah et al., 2006; Katz et al.; 2005, Kern et al., 2006; Lorenz 
et al., 2008; Lin et al., 2008; Noël et al., 2008; Rebelatto et al., 2008; Wagner et al., 2005; 
Yoshimura et al., 2006; Zuk et al., 2001; Zuk et al. 2002). Cell surface molecules CD14, CD29, 
CD31, CD34, CD45, CD73 and CD105 were determined to be markers commonly used for 
selecting a pure population of mesenchymal stem cells from the stem cell niches of bone marrow 
(BM-MSC), adipose tissue (ASC), umbilical cord stem cells (Rebelatto et al., 2008), and even 
stem cells found in menstrual blood (Meng et al., 2007). 
As anticipated, flow cytometry analysis of early passage (PD 4-6) ASC-8, ASC-9, and 
BM-MSCs all show a typical MSC immunophenotype of CD14-, CD29+, CD31-, CD34 low/+,  
CD45-, CD73+, CD105+. These cells were not pre-sorted prior to flow cytometric analysis. 
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These cell lines were all selected by density gradient separation for mononuclear cells during 
their primary isolations, and only further selected on the basis of adherence to plastic and growth 
as adherent cells in ASC media after their initial isolation, and alternative methods may produce 
differing results. Interestingly, BJ fibroblasts, a mature, fully differentiated somatic cell type, 
express an immunophenotype of CD14-, CD29+, CD31-, CD45-, CD73+, CD105+, virtually 
indistinguishable from ASCs or BM-MSCs.  
The shared immunophenotype between ASCs, BM-MSCs, and BJ fibroblasts strongly 
argues that other markers for somatic stem cells must be used or other methodologies employed, 
such as differentiation potential or perhaps gene expression profile to distinguish a true 
progenitor cell. These results argue against the use of costly and time-consuming flow cytometry 
for characterizing MSCs as requisite for confirming the identity of MSCs as MSCs, at least until 
better cell surface markers for characterization can be found, if such unique markers or 
combination of markers even exists. Large immunophenotype screens have been done in many 
laboratories in an attempt to find a unique ASCs fingerprint without success, suggesting that 
uncovering such a marker seems unlikely.  
Comparing ASCs strains we derived using the established isolation method (Zuk et al., 
2002), our ASCs also exhibited the expected multipotent differentiation potential and the typical 
lack of telomerase activity (not shown, pending publication, Francis and Sachs et al., 2010). We 
were also successful in rapidly isolating ASC in a streamlined 30-minute extraction process with 
characteristics indistinguishable from traditionally isolated ASCs and other MSC lines tested, 
presenting a modified technique that could lead to considerable time and cost savings (Francis et 
al., 2010). A method for rapidly deriving ASCs from lipoaspirate saline/blood in a minimally 
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equipped lab or hospital setting may even speed the realization of patient-derived stem cell 
therapies becoming common practice.   
While ASCs were selected as an ideal progenitor cell type for previously mentioned 
reasons, embryonic or induced pluripotent stem cells (iPS) may prove superior still in generating 
the complexities of mature tissue, such as bone, in the laboratory and in the body. However, 
ASCs have not yet been shown to contribute to tissue resembling a wound blastema, such as that 
arising from the marrow of fractured bone and in the leading edge of all regenerating tissue. True 
pluripotent cells can form such blastema-like tissue and may prove (perhaps in concert with 
MSCs) to be important cells for generating complex tissues in vitro and in vivo, and this should 
be explored further. 
 
Electrospun Fibrinogen, Osteoblastogenesis, and ASCs 
Our results of chapter 5 show that electrospun Fg and Fg:PDO are excellent materials for 
ASC proliferation and osteogenic differentiation, and present a solid biomimetic system to 
further bone model-based research.  
The initial experiments with ASCs seeded on cross-linked electrospun fibrinogen 
produced a largely impenetrable scaffold with a thin confluent layer of cells on the scaffold 
surface. While cross-linking may prove advantageous in some regards for enhancing mechanical 
integrity of the scaffold as it exists in vitro (Sell et al., 2008, McManus et al., 2006, 2007), the 
results presented here argue against cross-linking for creating a highly cellularized artificial 
scaffold, as a scaffold that has only a thin confluent layers of cells on the exterior is likely of 
limited utility clinically.  
   
 132 
We have recently discovered that the shrinkage of pure fibrinogen observed can be 
largely prevented through weighing down the scaffold when it is hydrated to retain its original 
macroscopic size and shape, and logically generating larger pores and a more open architecture 
promoting cell infiltration. Though porosity measurements have not been made on unshrunken 
fibrinogen, it stands to reason that, without macroscopic shrinkage, little or at least less 
microscopic shrinkage is to be expected, removing another of the benefits of rigid chemical 
(rather then natural or biological) cross-linking. 
Using unfixed scaffolds, ASC cellularity in fibrinogen was excellent, with a dense layer 
of cells found in the exterior of the scaffold and many cells throughout the scaffold by only 7 
days of culture in either regular ASC growth media and also in osteogenic induction media. 
Fg:PDO blended scaffolds had high cellularity, with significantly more cells than found on PDO, 
yet reduced levels of cell proliferation over time from quantitated Ki67 data. Fg:PDO scaffolds 
with ASCs show extensive new collagen being deposited by the cells through trichrome staining. 
Pure PDO scaffolds were bereft of ASCs inside the scaffold and overall proved a poor substrate 
for ASCs in these studies. Further research is required to determine why PDO blended scaffolds 
had reduced bioactivity relative to pure fibrinogen scaffolds, and blending electrospun fibrinogen 
with other synthetic materials, such as PEG and PLGA, and even with other natural materials, 
such as collagen and silk, could prove highly informative.  
Unexpectedly, MG63 osteosarcoma cells, used as a control to approximate osteoblasts, 
appeared highly active upon fibrinogen scaffolds, consuming the scaffold in a matter of days via 
an unknown mechanism, yet unlike ASCs or fibroblasts, MG63 cells did so without depositing a 
new support matrix in the process. This scaffold breakdown may be linked to protease secretion, 
   
 133 
a common feature of many cancerous cells, which may be significant in modeling the stages of 
fracture healing. As the fibrinogen-containing hematoma forms early during fracture healing, it is 
quickly consumed by osteoblasts, and other precursor cells infiltrate the primordial healing 
matrix. Closer examination of this phenomenon is highly warranted, perhaps using normal 
osteoblast strains or fully differentiated osteoblasts derived from BM-MSCs or ASCs seeded 
directly onto the fibrinogen scaffold. In this type of system, we could then observe scaffold 
disintegration, assay for new collagen production, and also test mechanical strength. In other 
cancer-based studies with possible links to our research, using artificial bone generated from 
electrospun fibrinogen and MSCs may provide an excellent culture model system for studying 
the mechanism of breast or pancreatic cancer metastasis to bone. 
Regarding material selection for modeling osteogenesis on electrospun scaffolding, it is 
arguable that collagen type I may be a superior material for modeling and stimulating 
osteogenesis, with type I collagen being the native and predominant ECM of mature bone. In 
fact, many studies have already shown electrospun collagen fibers to be a suitable template for 
bone differentiation and for potentially engineering bone in vitro (Ekaputra et al., 2009; 
Prabhakaran et al., 2009; Chan et al., 2009; Venugopal et al., 2008; Shih et al., 2006; Sefcik et 
al., 2006.). Though using collagen as a substrate for growing bone has clear advantages, collagen 
is typically only available from rat tails or bovine sources, which are problematic therapeutically. 
Human collagen, which would likely be far less immunoreactive than the xenogenic collagens, is 
not readily available or cost effective. Autologous collagen I is not currently harvested in large 
quantities without extreme patient morbidity associated with removing skin grafts. 
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Fibrinogen, however, can be readily harvested from the patient though simple blood 
collection. Fibrinogen is also potentially available in immense quantities though blood/plasma 
clinics, as fibrinogen is removed from donated blood and plasma prior to use and is generally 
discarded. Future studies may include isolating fibrinogen from the blood/saline phase of 
lipoaspirate for subsequent electrospinning and seeding with syngeneic ASCs. Additionally, a 
staggering amount of liposuction material, rich with basement membrane extracellular matrix 
and type I collagen, is discarded in the U.S. and therefore could potentially be used as a source of 
human collagen. 
In these experiments, differentiating ASCs to bone while seeded upon electrospun 
fibrinogen provided an encouraging topological change by producing what appears to be a 
calcification on pure fibrinogen constructs. This feature was absent on acellular control scaffolds, 
on BJs seeded on fibrinogen, and on pure PDO-containing scaffolds with ASCs, even when 
grown in osteogenic media, which eliminates any possible interaction with the salts present in 
the differentiation media as being the causative factor responsible for these changes. Supporting 
the apparent matrix calcification found by SEM, the intense Alizarin Red S staining observed on 
Fg:PDO and particularly on pure fibrinogen scaffolds further asserts progression towards mature 
bone formation though presence of a highly calcified ECM. However, quantitation of the 
mineralization with time and as compared to acellular, and BJ, and BM-MSC seeded scaffold 
controls, is still required to determine the relative rate and extent of mineralization on 
electrospun fibrinogen, Fg:PDO, and PDO scaffolds. 
While our qPCR results from pure fibrinogen scaffold were highly informative and 
support our findings that electrospun fibrinogen supports osteoblastogenesis from ASCs, future 
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studies could further this work. Our qPCR studies, as originally designed, included a comparison 
of Fg to Fg:PDO scaffolds for all genes tested yet, for assorted technical reasons, the results 
proved less informative then as originally designed. These studies could be replicated to directly 
compare the Fg and Fg:PDO scaffolds’ ability to support osteoblastogenesis at the molecular 
level. For future studies, qRT-PCR could be performed on pure Fg and Fg:PDO scaffolds seeded 
with ASCs with collection of specimens over a finer time course (days 1, 3, 5, 7, 10, 15, 20 and 
30) from cells in control and osteogenic media. This would permit a better assessment of the 
expression levels of genes typified of early to late osteoblastogenesis. Changes in gene 
expression with time could be followed with the genes products of Runx2, alkaline phosphatase, 
osteopontin, osterix, osteonectin, and osteocalcin to assess the rate and extent of 
osteoblastogenesis, to determine any difference as compared to the different scaffold material 
types, and to compare with other stem cell types, such as BM-MSCs or iPS cells. Lastly, while 
our studies focused on osteoblastogenesis, the ability of electrospun fibrinogen to support the 
differentiation of ASCs to adipocytes, chondrocytes, myocytes, and neurons would be another 
worthwhile avenue of exploration. 
 
 
Electrospun Adipose Tissue Extracellular Matrix 
The derivation of an ECM from adipose tissue (At-ECM) that can be electrospun may 
hold immense promise for future development. It is conceivable that such ECM would be an 
excellent substrate for the culture of ESC or induced pluripotent (iPS) stem cells, which currently 
require either mouse feeder cells or Matrigel® to successfully sustain an undifferentiated state in 
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culture. Should adipose tissue be able to support pluripotency of stem cell, it would be a 
significant breakthrough for 1) removing possible xenogenic contamination from mouse-derived 
feeder or ECM contributions, and 2) possibly leading to an autologous matrix material for one 
day deriving autologous iPS cells that will speed clinical development and translation for iPS 
technologies. 
 We showed here for the first time that At-ECM can be electrospun into a scaffold 
retaining large amounts of collagen type I and basement membrane components (collagen type 
IV, elastic fibers, and glycosaminoglycan-based ECM), while further supporting human ASCs.  
Interestingly, the amount of VVG staining for proteoglycans, glycosaminoglycans, and 
glycoproteins was extensive on electrospun At-ECM. This result may have been expected as 
these ECM materials are found tightly bound through covalent cross-linking in connective tissue 
ECM and are ECM components also found in fat shown to integrate in electrospun At-ECM. 
Characterization of the At-ECM extracted, however, remains incomplete. Western blot 
analysis on At-ECM as compared to Matrigel and to purified matrix standards of collagens I-XII, 
laminin and fibronectin and potentially other ECM components likely present in At-ECM is 
required to better characterize the material composition of adipose tissue ECM. Alternatively, 
MALDI-TOF mass-spec would be another highly useful, perhaps superior tool to determine the 
fat ECM composition both after extraction and post-electrospinning. As the electrospinning 
process likely recombines the various ECM polymers in a unique fashion, it may prove 
informative to assay both At-ECM and fibrinogen both pre- and post-electrospinning to 
characterize their composition, as well as testing for the availability of various cell and integrin 
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binding sites present on native ECM that may or may not be presented on other electrospun 
analogues. 
While we showed cell attachment to electrospun At-ECM and At-ECM:PDO, additional 
studies may prove highly informative and valuable for further supporting the significance of this 
material in basic research and for therapeutic purposes. For instance, we could determine 
proliferation of ASCs on these scaffolds (PCNA, Ki67), assessing differentiation potential and 
the immunophenotype of ASCs cultured on this material, determine the immunophenotype of 
ASCs cultured on electrospun At-ECM as compared to tissue culture plastic, and assess the 
immune response of electrospun At-ECM with in vivo animal models  
 
SUMMARY 
 
In summary, we show that ASCs can be isolated in a traditional and expedited manner, 
and they differentiate into fat, cartilage, and bone and are nearly indistinguishable from BMSCs 
with respect to these important, established stem cell markers. We show that immunophenotype 
alone is not sufficient to identify MSCs from fibroblast. We further show ASCs can grow into 
electrospun scaffolds of fibrinogen and a fibrinogen:PDO blend, while further supporting 
osteogenic differentiation, as determined by mineral, nucleic acid and protein analyses. Also we 
have engineered the derivation of an entirely novel material for tissue engineering purpose in 
electrospun adipose tissue ECM, which was found to be largely composed of collagen type I and 
basement membrane components (collagen type IV, elastic fibers, and glycosaminoglycans), and 
also capable of supporting adipose stem cells. The data generated in these studies provides the 
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framework and working model for combining both potentially autologous stem cells and 
biomimetic extracellular matrices from patient-derivable sources, with future clinical 
applications including, yet not limited to, the repair, replacement, and regeneration of bone. 
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-Appendix A- 
Cell Response to Crosslinked vs. Uncrosslinked Fibrinogen  
 
 
To determine the feasibility of using ASCs and electrospun fibrinogen together as a 
starting template for tissue engineering mature, biomimetic tissue types, we first need to show 
that ASCs are 1) adherent, 2) viable long term, 3) able to penetrate the scaffold and 4) able to 
synthesis natural matrix de novo in electrospun fibrinogen (Fg) scaffolds. To test these 
parameters, approximately 50,000 ASCs were seeded on 10mm discs cut from electrospun 
fibrinogen or a fibrinogen:elastin 50:50 blend, and cultured for up to 2 weeks. The scaffolds 
were fixed then paraffin embedded and section for H&E and Masons Trichrome staining at days 
7 and 14. Initial tests showed what appeared to be a single cell layer thick confluent sheet of 
ASCs atop of the electrospun fibrinogen at day 7 and 14 in culture, and with cells only on the 
periphery of the matrix on a fibrinogen:elastin blended scaffold (Fig 46). However, the ASCs 
were unable to effectively penetrate the Fg scaffolds, which were genipin cross-linked for 
enhanced mechanical properties (Sell et al. 2008). Trichrome stains of the genipin cross-linked 
electrospun fibrinogen scaffolds seeded with ASCs showed few patches of new collagen 
synthesis with limited penetration into the scaffold up to 14 days in culture (Fig. 47), putting the 
practice of cross-linking fibrinogen into question if a highly cellularized scaffold was a desired 
feature of the finished product. 
Following these initial observations, we next set out to assess any phenotypic changes at 
the nanoscale level that cross-linking may impart on electrospun fibrinogen. SEM images of pre-
and post-cross-linked fibrinogen treated with the various cross-linkers were acquired to gain  
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Figure 46. Cross-linked Fibrinogen Histology. H&E staining of ASCs seeded upon genipin 
cross-linked fibrinogen at day 7 (A) and day 14 (B) show viable cells yet limited scaffold 
penetration (arrows indicated cells). A cross-linked blend of 50:50 elastin:fibrinogen also 
showed a lack of ASC penetrating the scaffold at day 14 (C). 
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Figure 47. Limited New Collagen Production on Cross-linked Fibrinogen. Masons 
Trichrome stain of genipin cross-linked fibrinogen at day 14 shows limited new collagen 
synthesis in only spotted patches near the scaffold exterior at 20x (A) and 40x (B). 
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insight into any apparent alterations in the scaffold topography and fiber morphology (Fig. 48).  
Each scaffold was ethanol soaked, dehydrated, then gold sputter coated prior to SEM analysis. 
The SEM images largely show an apparent extensive fusing of fibers and densification of the 
scaffolds from the cross-linking processes, as is to be expected with extensive cross-linking. 
 We next sought to measure any alteration in the scaffold porosity related to cross-linking. 
Much of total void space was maintained with any type of cross-linking in comparison to 
uncross-linked scaffolds. However, porosity decreases in control scaffolds that were unfixed or 
ethanol soaked, and GLUT cross-linking produced a measurable decrease mean scaffold porosity 
(Table 10). Genipin produced a minimal difference between PBS soaked and dry discs, with 
minimal densification, while EDCs affect on porosity appeared insignificant. 
To determine the cellular activity on cross-linked vs. non-cross-linked fibrinogen 
scaffolds, SEM analysis was used to provide qualitative information on cell migration across the 
scaffolds surface and for assessing cell viability on scaffolds with time (Fig. 49). H&E and 
Trichrome stains show both migration into the scaffolds interior and on its surface, and the extent 
of new collagen production (Fig. 50). BJ-GFP-hTERT fibroblast were used in these studies as 
fibroblasts have been the standard reference cell type in such systems, with the GFP-hTERT 
modified cells selected for easy cell tracking in prospective future experiments and for producing 
a more stable proliferative cell type. A clear increase in staining intensity is apparent atop all of 
the cross-linked scaffolds at 21 days of culture vs. 7 days, suggesting the persistence of cells atop 
of the scaffold (Fig. 50). While cells were only present in spotted areas on the scaffolds at day 7, 
all scaffolds were highly covered over their surface by day 21, suggesting good migration atop  
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Figure 48. SEM of Fibrinogen Cross-linked by Multiple Methods. Scanning electron 
micrographs (8000x) of acellular electrospun fibrinogen scaffolds treated with GLUT (A), 
ethanol (B), EDC (C), and genipin (D) are shown (From Sell et al. 2008).
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Table 11: Mean Scaffold Porosities of Cross-Linked Fibrinogen Scaffolds#.  
 
#(adapted from Sell et al. 2008) 
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Figure 49. SEM analysis of BJ-GPF-hTERT Fibroblasts Seeded Upon Electrospun 
Scaffolds. SEM shows the presence of BJs on the scaffold surface with each cross-linking 
chemical at days 7 and 21 at 498X (from Sell et al. 2008). 
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Figure 50. Cross-linked Fibrinogen Histology.  H&E and Mason’s Trichrome stained cross-
linked fibrinogen scaffolds seeded with BJ-hTERT fibroblasts are visualized by optical light 
microscope at 40x.  Trichrome stained samples show fibrinogen in a native red coloration, where 
new collagen synthesis stains appear blue (Sell et al. 2008). 
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the cross-linked and the native spun scaffolds. Conversely, cells did not appear to penetrate the 
scaffold exterior of the cross-linking specimens (Fig. 50). We then followed new collagen 
production via Trichrome stained samples at 21 days of culture. While control and uncross-
linked scaffolds were near completely composed of newly synthesized collagen (blue staining), 
GLUT cross-linked scaffolds exhibited only a gradual transition to new collagen, with genipin 
and EDC cross-linked scaffolds exhibiting little new collagen production or matrix remodeling.  
  Noting the deleterious affects of chemical crosslinking in these studies, we next sought to 
assess the ability of ASCs to attach, proliferate and migrate upon native, un-cross-linked 
electrospun fibrinogen. 50,000 ASCs at PD4 or approximately PD25 were seeded on 10mm 
electrospun fibrinogen scaffolds discs and cultured for 7, 14, 21 and 28 days.  The ability for 
ASCs to penetrate into the interior of uncross-linked fibrinogen was determined by H&E. These 
un-cross-linked scaffolds had cellularity into the scaffold interior at all time points (see chapter 
4).  
 
Summary: 
 Thus, we show here that chemical cross-linking of fibrinogen scaffolds is linked to a 
negative effect on the cell response for both ASCs and BJs fibroblasts, leaving the scaffolds 
largely impenetrable. While cells will attach to cross-linked fibrinogen, cells appear to more 
rapidly penetrate into the scaffold if left in a native, uncross-linked form. Noting by H&E 
sections that uncross-linked scaffolds showed cells inside of the scaffolds at early and late time 
points, cross-linking was thus avoided in all the following experiments, which are encompassed 
in chapter 5. 
   
 159 
-Appendix B- 
Bioelectrospinning 
 
Our preliminary studies taught us that synthesizing a natural appearing biological tissue 
enriched with progenitor cells is an arduous task using conventional cell seeding methods on 
cross-linked electrospun scaffolds. Decreasing the time needed to cellularize an electrospun 
scaffold is important for producing workable research models, as well as for potentially 
developing a clinically relevant system. Appreciating the limitation of conventional scaffold 
seeding, a method for simultaneously electrosprayed ASCs and matrix material together, in a 
process here termed “bioelectrospinning” (Fig. 52), was used to rapidly produce a highly 
cellularized tissue construct. This process produces sheets of cellularized scaffold material with 
entrapped stem cells in around 30min (instead of  around 30 days), producing an evenly colored 
pink scaffold (pink from phenol red dye-containing media) (Fig. 53A). Scaffolds produced by 
this bioelectrospinning process show large numbers of apparent cell clusters visible under light 
microscopy (Fig. 53B-C, D-I).  
After optimizing many critical parameters in the bioelectrospinning process, as described 
in the main methods section, the bioelectrospun constructs created remained moist throughout 
the bioelectrospinning process and cells remained viable for up to a month after the 
bioelectrospinning process. Initial “test” or acellular control bioelectrospun scaffold sheets were 
formed by electrospraying media alone into the spinning matrix, used to setup the intricate 
electrospraying parameters, and also for use as a negative, acellular control in later experiments 
(Fig. 53D).  
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Figure 51. Bioelectrospinning Illustration. Modifying the standard electrospinning apparatus, a 
syringe filled with cells and media each placed on a syringe pump, is “jumpered” to a syringe 
containing an extracellular matrix polymer solution, thereby connecting both syringes to a high 
voltage power supply. With the syringes slowly presenting polymer/ECM and cells/media the 
high voltage power supply draws nanofibers out of the polymer that deposit in the rotating 
mandrel scaffold collection target, while the voltage creates an electrospraying effect. The stem 
cells, with media, are concurrently sprayed into the spinning fibrous scaffold. 
 
 
   
 161 
 
 
Figure 52. Bioelectrospun ASCs in Fibrinogen:PDO Histology.  ASCs concurrently spun 
within spinning Fg:PDO are shown at the macroscopic level, with a wet, evenly pink sheet of 
tissue construct formed from the process (A). An acellular control was spun for reference (D). 
Scaffolds created by this process are shown unstained under phase microscopy (B, E, H) and as 
H&E stained (C, F, G, I). 
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In developing the bioelectrospinning process, ASCs were initially encapsulated in 
alginate, a viscous gum derived from brown algae and widely used in tissue engineering for cell 
immobilization and cell encapsulation, to protect cells from possible harm endured from the 
electric field and organic solvent, and to keep the cells moist during the electrospraying process. 
However, the alginate, mixed at the predetermined ideal 25% concentration for spraying the 
cells/media (with ABAM), produced scaffolds with poor mechanical properties. Scaffolds with 
alginate-encapsulated cells quickly dissolved in static culture in 5-7 days, and these scaffolds did 
not last more than 72 hours in bioreactor cultures before disintegrating. A 50:50 fibrinogen:PDO 
scaffold was used in all bioelectrospinning experiments as the electrospun fibrinogen alone 
dissolved on the mandrel when electrosprayed with media/cells, and the PDO alone had proven a 
poor substrate for ASC growth and differentiation by this point. 
We proceeded to concurrently spray ASCs in media without alginate or other protectant 
into the electrospinning fibrinogen:PDO, which faired more stable in culture then alginate-
containing scaffolds. Cells sprayed into the spinning matrix remained viable within the solid, 
stable construct for at least 6 weeks. Bioelectrospun ASCs were readily dissociated from the 2 
week old scaffolds with vigorous pipetting agitation. These released cells were able to be re-
cultured and expanded on plastic where they maintained a normal morphology, growth rate and 
maximum cumulative PD, suggesting that the process did not damage the cells. 
After optimizing the intricate electrospraying/bioelectrospinning process, the ability of 
the scaffolds to support differentiating stem cells within the construct was next tested. 2x107 
ASCs (both ASC-8 and ASC-9) were spun in 50:50 fibrinogen:PDO blended scaffold sheets, 
from which 10mm punches were collected and left in static culture for 12 hours to promote cell 
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attachment and proliferation. The next day, punches where placed in 4 separate rotating vessel 
bioreactors filled with either normal growth media, osteogenic differentiation media, adipogenic 
media, or treated for 24hrs with 5-azacytidine, a global demethylating agent shown to induce 
cardiomyocyte differentiation in MSCs. Adipogenic and myogenic differentiation were included 
to validate the multipotential differentiation capacity of ASCs in bioelectrospinning process. A 
bioreactor with an acellular bioelectrospun sheet of fibrinogen:PDO and osteogenic media was 
included for a negative control.  
Preliminary SEM work showed promising results, particularly in stimulating bone 
synthesis. While a control cell-free scaffold had a familiar acellular fibrinogen:PDO appearance 
under SEM (Fig 54F), only scaffolds with cells grown in osteogenic media produced distinct, 
porous, honeycomb-like structures (Fig. 54A-E). Bone induced scaffolds at 3 weeks of 
differentiation were phenotypically hard and brittle, while the control scaffolds remained pliable. 
Scaffolds in adipogenic and myogenic media also showed a pronounced change in topography 
under SEM analysis as shown in Figure 55. At this point, equipment issues, notably the loss of 
the electrospinning translator apparatus and the power supplies requisite for the process, 
precluded any further experiments and no further lines of research could be explored using this 
bioelectrospinning process. 
 
SUMMARY: 
While cells are typically seeded upon electrospun matrices on the outside, with days to 
weeks or months of time given for cells to penetrate throughout the construct, it has recently 
been shown that myocytes, fibroblasts and zebrafish eggs can be concurrently sprayed into  
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Figure 53. Topography of Osteo-Induced ASC Seeded within Fibrinogen. ASCs were 
bioelectrospun into Fg:PDO and placed in bioreactor culture for 21 days (A-E) with osteogenic 
differentiation media, then visualized under SEM. An acellular control was also formed and 
grown in a bioreactor with osteogenic media (F). 
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Figure 54. Topography of Bioelectrospun ASC Differentiated to Fat and Muscle. ASCs 
were bioelectrospun into Fg:PDO and placed in bioreactor culture for 21 days with adipogenic 
(A, C) or myogenic (B,D) differentiation media, then visualized under SEM for unique 
topographical features. 
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electrospinning fibers, thereby rapidly producing a highly cellularized tissue analogue rich with 
cells entrapped in a biomimetic nanofibrous mesh (Stankus et al, 2006 & 2007). 
Bioelectrospinning has gained considerable popularity since our studies have been conducted. 
Remarkably, the bioelectrospraying process appears not to affect karyotypic stability or alter the 
normal development of electrosprayed cells, and also allows robust mesenchymal stem cell 
differentiation in the bioelectrospun scaffold (Gupta et al. 2009, Mongkoldhumrongkul et al. 
2009, Geach et al. 2009, Maeng et al., 2009, Hall et al. 2008). Clarke et al. (2008) were even able 
to electrospray zebrafish embryos and show that viable, normally developed adult fish are 
produced even after being subjected to the high voltage electrostatic field. Electrospraying can 
also be useful for material deposition, such as spraying a scaffold with hydroxyapatite to speed 
or even induce the osteogenesis process. 
 With the importance of the ECM in development and the stem cell niche in mind, 
entwining cells in a true 3D scaffold rather then seeding cells on one side of a scaffold may 
prove highly important in directing the cell bioactivity, for changes in cell metabolism, migratory 
and proliferative activity, and even in altering a cells differentiation potential, its rate of 
differentiation and gene expression, all of which should be further explored in this process. 
Following this path, the next step in advancing electrospun tissue engineered scaffolds will be 
applying highly proliferative, karyotypically stable yet potent stem cells, such as ASCs, to this 
matrix. 
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APPENDIX METHODS 
Cross-linking 
Glutaraldehyde Cross-linking.  Scaffolds were placed in 50% glutaraldehyde (GLUT) 
(Fisher Scientific) vapor chamber at RT for 1 hour. For constructing the vapor chamber, 2ml of 
GLUT in an open 35mm Petri dish was situated inside a 100mm diameter Petri dish, with 
scaffolds laid inside the large dish, then parafilm sealed. After the 1hr incubation, the scaffolds 
were removed and allowed to degas for an additional hour.  
EDC Cross-linking.  The 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) 
(Sigma) cross-linking protocol used in this study was modified from a similar protocol used to 
cross-link electrospun type II collagen (Barnes et al. 2007). Based on the molecular weight of 
fibrinogen (340kDa), the molarity of the electrospun fibrinogen solution was determined to be 
0.35mM. From this, an EDC solution at a 50-fold molar excess (17.6mM) was created by 
dissolving the cross-linker in pure ethanol (Fisher Scientific). Electrospun scaffolds were placed 
in 50ml of cross-linking solution for 18hr at RT, followed by a 2hr rinse in 0.1M sodium 
phosphate to hydrolyze any unreacted O-isoacylurea intermediates. 
Genipin Cross-linking.  The genipin cross-linking protocol used was similar to that of the 
EDC cross-linking protocol and was modified from a published protocol to cross-link porcine 
pericardia (Sung et al. 1998). Genipin powder (Wako Pure Chemical Industries, Ltd., Osaka, 
Japan) was dissolved in pure ethanol to a concentration of 30mM. Fibrinogen scaffolds were 
placed in 50ml of cross-linking solution for 72hrs at RT.  It has been reported that when the 
genipin cross-linking process is complete, the cross-linked material transitions to a dark blue or a 
brownish color (Ferretti et al. 2006). As such, it was noted that the electrospun fibrinogen 
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scaffolds gradually changed color over the 3-day period, eventually reaching dark blue near the 
end of day 3. Scaffolds were removed from the cross-linker solution at the completion of the 
time course. 
Controls.  As both the EDC and genipin cross-linkers were dissolved in ethanol for 72hrs, 
a pure ethanol solution left on discs for an equal duration served as a control to ensure that the 
cross-linking effects were a result of the cross-linkers rather than the ethanol. 
 
Bioelectrospinning 
To simultaneously electrospray stem cells within a concurrently spinning 
Fibrinogen:PDO matrix, the matrix needle air gap to receiver mandrel distance was set at 10-
12cm. The cell and media containing needle air gap to receiver mandrel distance was set to 
precisely 4.5cm. Cell/media flow rate was set at 12-15ml/hr, while the rate of matrix expulsion 
of 3ml/hr was found to be ideal. At least 2x107 stem cells were used per 500mg of scaffold for 
good cellularity throughout. The use of two 10ml syringes on a dual syringe pump for 
electrospraying cells and 4 or more 5ml syringes of fibrinogen/PDO was required to form the 
scaffold rapidly (under 20min), in order to prevent scaffold drying and improve cell viability. A 
round 10cm diameter receiver mandrel was used to avoid turbulence induced by rectangular 
mandrels, which also improved cell and media deposition on the bioelectrospun construct. 
Constructs produced an evenly pink colored media distribution, made without electrical arching 
from the needles, allowing good matrix/cell deposition for a rapid synthesis, keeping the 
construct moist throughout the bioelectrospinning process. For all experiments, an initial “test” 
sheet was formed with only electrospraying media into spinning matrix, which was used to 
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pretest the delicate setup parameters and as a negative or acellular control. 
Bioreactor Cultures  
Forty-eight 10mm scaffold discs were punched from the sheet formed with cells in the 
bioelectrospinning process, with 12 being punched from the control acellular sheet. A total of 12 
scaffolds were destined for 5 separate bioreactors. Four autoclaved 55ml Slow Turning Lateral 
Vessel (STLV) bioreactor chambers were setup on the Rotary Cell Culture System (RCCS) 
(SyntheconTM). The vessels were conditioned prior to use and tested for leaks by filling with PBS 
to check for major leakage, then drained and filled with media and the vessels allowed to rotate 
for 2hrs to check for minor leaks. 12 scaffolds were placed in each bioreactor under sterile 
conditions, with one reactor containing the acellular bioelectrospun scaffold and osteogenic 
induction media, and 4 vessels containing bioelectrospun scaffold, one filled with basic ASC 
growth media, one containing osteogenic induction media, one with adipogenic media, and the 
fourth with myogenic induction media containing 5-Azacytadine. These 5 bioreactors used 4 
distinct medias, and half of the media was changed every 2 days for 3 weeks. Cultures were 
performed under the standard conditions of 37ºC at 5% CO2 in a humidified incubator. The rates 
of rotation required for suspending the scaffold discs in a perpetual freefall in the vessels was 
determined experimentally and adjusted as needed at each media change. In general, 17 RPM 
was sufficient to maintain the discs in freefall throughout the tissue development, except for 
osteogenic media containing vessel with cells, which required 27 RPM after a week of culture. 
 
Fiber Diameter and Pore Size Measurement of Dry Scaffolds 
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SEM images of pore morphologies, fiber orientation and fibers size of dry electrospun 
sheets were captured using a Zeiss Evo50 scanning electron microscope using ImageJ64 (NIH 
shareware) to measure fiber diameter and pore size. 50 separate fiber diameter and 40 pore area 
measurements were used to determine the mean and standard deviation, with calibration for each 
image made with a corresponding scale bar.  
 
Scaffold Porosity Measurement 
Previous work has shown that electrospun fibrinogen scaffolds will contract and densify 
when placed in an aqueous solution (Barnes et al., 2007). For determining what effects cross-
linking in GLUT, ethanol soaking, EDC, and genipin had on scaffold densification, the scaffold 
porosity was determined for each cross-linker and compared to uncross-linked fibrinogen 
samples. For each sample, 21mm diameter discs were punched from uncross-linked electrospun 
fibrinogen scaffolds in their dry state. The thickness and dry mass of the scaffolds were recorded, 
with the porosity or void fraction of the disc determined by as before (Sell et al., 2002):  
! 
Void Fraction =1"
Calculated Scaffold Density
Known Material Density
x100
# 
$ 
% 
& 
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(     
Calculated scaffold density was determined by dividing the disc mass by the discs total 
volume, using 1.38g/cm3 as the known dry density of fibrinogen (McManus et al., 2006). Discs 
were cross-linked as previously described with punches rinsed in PBS three times to remove any 
remaining cross-linker and soaked in PBS for 24hrs at RT. The next day, the thickness and 
diameter of the discs were recorded to determine the wet total volume after the PBS soak and 
following ethanol rinses. Using the void fraction equation, the hydrated void fraction was 
determined. By dividing the disk dry mass by the determined altered total volume of the hydrated 
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discs the hydrated calculated scaffold density was determined, which was then divided by the dry 
density of fibrinogen. Dry density and mass were used based on the assumption that the presence 
of water or ethanol in the void spaces would account for the difference in mass, as the actual 
electrospun fibers are unlikely to lose or gain mass. 
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